<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome - Franik, S - 2022 | Cochrane Library</title> <meta content="Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome - Franik, S - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome - Franik, S - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010287.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome" name="citation_title"/> <meta content="Sebastian Franik" name="citation_author"/> <meta content="University Hospital Münster" name="citation_author_institution"/> <meta content="S.Franik@gmx.de" name="citation_author_email"/> <meta content="Quang-Khoi Le" name="citation_author"/> <meta content="University Hospital Münster" name="citation_author_institution"/> <meta content="Jan AM Kremer" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Center" name="citation_author_institution"/> <meta content="Ludwig Kiesel" name="citation_author"/> <meta content="University Hospital Münster" name="citation_author_institution"/> <meta content="Cindy Farquhar" name="citation_author"/> <meta content="The University of Auckland" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD010287.pub4" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/09/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Abortion, Spontaneous [epidemiology]; *Anovulation [complications, drug therapy]; Aromatase Inhibitors [adverse effects]; Clomiphene [adverse effects]; Fertility Agents, Female [adverse effects]; *Infertility, Female [drug therapy, etiology]; Letrozole [therapeutic use]; Live Birth [epidemiology]; *Ovarian Hyperstimulation Syndrome; Ovulation Induction [methods]; *Polycystic Ovary Syndrome [drug therapy]; Pregnancy Rate; Selective Estrogen Receptor Modulators [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010287.pub4&amp;doi=10.1002/14651858.CD010287.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="cdmLYOAV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010287\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010287\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ko","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010287.pub4",title:"Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome",firstPublishedDate:"Sep 27, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=cdmLYOAV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010287.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010287.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010287.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010287.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010287.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010287.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010287.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010287.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010287.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010287.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>15072 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010287.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-sec-0149"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-sec-0042"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-sec-0133"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/appendices#CD010287-sec-0154"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/supinfo/CD010287StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/supinfo/CD010287StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information#CD010287-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Sebastian Franik</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information#CD010287-cr-0005">Quang-Khoi Le</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information#CD010287-cr-0006">Jan AM Kremer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information#CD010287-cr-0007">Ludwig Kiesel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information#CD010287-cr-0008">Cindy Farquhar</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information/en#CD010287-sec-0165">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 September 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010287.pub4">https://doi.org/10.1002/14651858.CD010287.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010287-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010287-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010287-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010287-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010287-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010287-abs-0005">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010287-abs-0001" lang="en"> <section id="CD010287-sec-0001"> <h3 class="title" id="CD010287-sec-0001">Background</h3> <p>Polycystic ovary syndrome (PCOS) is the most common cause of infrequent periods (oligomenorrhoea) and absence of periods (amenorrhoea). It affects about 5% to 20% of women worldwide and often leads to anovulatory infertility. Aromatase inhibitors (AIs) are a class of drugs that were introduced for ovulation induction in 2001. Since about 2001 clinical trials have reached differing conclusions as to whether the AI, letrozole, is at least as effective as the first‐line treatment clomiphene citrate (CC), a selective oestrogen receptor modulator (SERM). </p> </section> <section id="CD010287-sec-0002"> <h3 class="title" id="CD010287-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of AIs (letrozole) (with or without adjuncts) compared to SERMs (with or without adjuncts) for infertile women with anovulatory PCOS for ovulation induction followed by timed intercourse or intrauterine insemination. </p> </section> <section id="CD010287-sec-0003"> <h3 class="title" id="CD010287-sec-0003">Search methods</h3> <p>We searched the following sources, from their inception to 4 November 2021, to identify relevant randomised controlled trials (RCTs): the Cochrane Gynaecology and Fertility Group Specialised Register, CENTRAL, MEDLINE, Embase and PsycINFO. We also checked reference lists of relevant trials, searched the trial registers and contacted experts in the field for any additional trials. We did not restrict the searches by language or publication status. </p> </section> <section id="CD010287-sec-0004"> <h3 class="title" id="CD010287-sec-0004">Selection criteria</h3> <p>We included all RCTs of AIs used alone or with other medical therapies for ovulation induction in women of reproductive age with anovulatory PCOS. </p> </section> <section id="CD010287-sec-0005"> <h3 class="title" id="CD010287-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected trials, extracted the data and assessed risks of bias using RoB 1. We pooled trials where appropriate using a fixed‐effect model to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for most outcomes, and risk differences (RDs) for ovarian hyperstimulation syndrome (OHSS). The primary outcomes were live birth rate and OHSS rate. Secondary outcomes were clinical pregnancy, miscarriage and multiple pregnancy rates. We assessed the certainty of the evidence for each comparison using GRADE methods. </p> </section> <section id="CD010287-sec-0006"> <h3 class="title" id="CD010287-sec-0006">Main results</h3> <p>This is a substantive update of a previous review; of six previously included trials, we excluded four from this update and moved two to 'awaiting classification' due to concerns about validity of trial data. We included five additional trials for this update that now includes a total of 41 RCTs (6522 women). The AI, letrozole, was used in all trials. </p> <p><b><i>Letrozole compared to SERMs with or without adjuncts followed by timed intercourse</i> </b> </p> <p>Live birth rates were higher with letrozole (with or without adjuncts) compared to SERMs followed by timed intercourse (OR 1.72, 95% CI 1.40 to 2.11; I<sup>2</sup> = 0%; number needed to treat for an additional beneficial outcome (NNTB) = 10; 11 trials, 2060 participants; high‐certainty evidence). This suggests that in women with a 20% chance of live birth using SERMs, the live birth rate in women using letrozole with or without adjuncts would be 27% to 35%. There is high‐certainty evidence that OHSS rates are similar with letrozole or SERMs (0.5% in both arms: risk difference (RD) −0.00, 95% CI −0.01 to 0.01; I<sup>2</sup> = 0%; 10 trials, 1848 participants; high‐certainty evidence). There is evidence for a higher pregnancy rate in favour of letrozole (OR 1.69, 95% CI 1.45 to 1.98; I<sup>2</sup> = 0%; NNTB = 10; 23 trials, 3321 participants; high‐certainty evidence). This suggests that in women with a 24% chance of clinical pregnancy using SERMs, the clinical pregnancy rate in women using letrozole with or without adjuncts would be 32% to 39%. There is little or no difference between treatment groups in the rate of miscarriage per pregnancy (25% with SERMs versus 24% with letrozole: OR 0.94, 95% CI 0.66 to 1.32; I<sup>2</sup> = 0%; 15 trials, 736 participants; high‐certainty evidence) and multiple pregnancy rate (2.2% with SERMs versus 1.6% with letrozole: OR 0.74, 95% CI 0.42 to 1.32; I<sup>2</sup> = 0%; 14 trials, 2247 participants; high‐certainty evidence). However, a funnel plot showed mild asymmetry, indicating that some trials in favour of SERMs might be missing.  </p> <p><b><i>Letrozole compared to laparoscopic ovarian drilling (LOD)</i> </b> </p> <p>One trial reported very low‐certainty evidence that live birth rates may be higher with letrozole compared to LOD (OR 2.07, 95% CI 0.99 to 4.32; 1 trial, 141 participants; very low‐certainty evidence). This suggests that in women with a 22% chance of live birth using LOD with or without adjuncts, the live birth rate in women using letrozole with or without adjuncts would be 24% to 47%. No trial reported OHSS rates. Due to the low‐certainty evidence we are uncertain if letrozole improves pregnancy rates compared to LOD (OR 1.47, 95% CI 0.95 to 2.28; I² = 0%; 3 trials, 367 participants; low‐certainty evidence). This suggests that in women with a 29% chance of clinical pregnancy using LOD with or without adjuncts, the clinical pregnancy rate in women using letrozole with or without adjuncts would be 28% to 45%. There seems to be no evidence of a difference in miscarriage rates per pregnancy comparing letrozole to LOD (OR 0.65, 95% CI 0.22 to 1.92; I² = 0%; 3 trials, 122 participants; low‐certainty evidence). This also applies to multiple pregnancies (OR 3.00, 95% CI 0.12 to 74.90; 1 trial, 141 participants; very low‐certainty evidence). </p> </section> <section id="CD010287-sec-0007"> <h3 class="title" id="CD010287-sec-0007">Authors' conclusions</h3> <p>Letrozole appears to improve live birth rates and pregnancy rates in infertile women with anovulatory PCOS, compared to SERMs, when used for ovulation induction, followed by intercourse. There is high‐certainty evidence that OHSS rates are similar with letrozole or SERMs. There was high‐certainty evidence of no difference in miscarriage rate and multiple pregnancy rate. We are uncertain if letrozole increases live birth rates compared to LOD. In this update, we added good quality trials and removed trials with concerns over data validity, thereby upgrading the certainty of the evidence base. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010287-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010287-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010287-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010287-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010287-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010287-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010287-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010287-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010287-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010287-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010287-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010287-abs-0002" lang="en"> <h3>Aromatase inhibitors for infertility treatment in women with polycystic ovary syndrome</h3> <p><b>Review question:</b> Cochrane authors examined the evidence about aromatase inhibitors for infertile women with polycystic ovary syndrome (PCOS). </p> <p><b>Background:</b> PCOS is the most common cause of infrequent or absent menstrual periods, and affects about 5% to 20% of women worldwide. It often causes anovulatory infertility (infertility related to inability to ovulate). Aromatase inhibitors (AIs) are used to make ovulation happen. Since about 2001 clinical trials have reached differing conclusions as to whether the AI, letrozole, is at least as effective for treating infertility as the most commonly used treatment, clomiphene citrate. </p> <p><b>Trial characteristics:</b> The review includes clinical trials where participants were randomly assigned to the intervention (letrozole) or to the comparison group (i.e. clomiphene citrate). These trials are called randomised controlled trials. Our review includes 41 randomised controlled trials with 6522 women. In all trials, the aromatase inhibitor used was letrozole. Comparators included clomiphene citrate, which was used in 26 of the randomised controlled trials, and laparoscopic ovarian drilling (a surgical technique used to trigger ovulation), which was used in four randomised controlled trials. Several trials included other treatments. </p> <p><b>Key results:</b> Letrozole appears to improve live birth rates and pregnancy rates compared to clomiphene citrate when used to cause ovulation, followed by timed intercourse. There appeared to be no difference for miscarriage rate or multiple pregnancy rate. Ovarian hyperstimulation syndrome, a serious adverse event of hormonal stimulation, was a very rare event and in most trials it did not occur. The certainty of the evidence for all these outcomes was high and seems to be reliable. </p> <p>There appeared to be very low‐certainty evidence for higher live birth rates with letrozole compared to laparoscopic ovarian drilling, although there was only one relevant trial. The result for clinical pregnancy rate was uncertain. We are uncertain if letrozole decreases miscarriage and multiple pregnancy rates compared to laparoscopic ovarian drilling. No trials reported on ovarian hyperstimulation syndrome. The evidence is current to November 2021. </p> <p><b>Certainty of the evidence:</b> The overall certainty of the evidence ranged from very low to high. We downgraded evidence when we had small trials with few women or when methods were unclear. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010287-sec-0149" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010287-sec-0149"></div> <h3 class="title" id="CD010287-sec-0150">Implications for practice</h3> <section id="CD010287-sec-0150"> <p>Letrozole appears to improve live birth and pregnancy rates in infertile women with anovulatory PCOS, compared to SERMs, when used for ovulation induction, followed by intercourse. There is high‐certainty evidence that OHSS rates are similar with letrozole or SERMs. There was high‐certainty evidence of no difference in miscarriage rate and multiple pregnancy rate. We are uncertain if letrozole increases live birth rates compared to LOD. In this update, we added good quality trials and removed trials with concerns over data validity, thereby upgrading the certainty of the evidence base. </p> </section> <h3 class="title" id="CD010287-sec-0151">Implications for research</h3> <section id="CD010287-sec-0151"> <p>For letrozole compared to placebo, additional trials are not necessary, since there is evidence in favour of letrozole compared to CC, which was proven to be more effective compared to placebo for live birth and pregnancy rates (<a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0036" title="Sheikh-El-Arab ElsedeekM , ElmaghrabyHA . Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal2011;16(2):125-30. ">Sh‐El‐Arab Elsedeek 2011</a>). Further RCTs could also be conducted, investigating a 5‐ or 10‐day administration protocol and day 3 to 5 or day 5 to 9 administration of letrozole.   </p> <p>Overall, it is very important for fertility trials to report on the standardised core outcome set for fertility trials as suggested by <a href="./references#CD010287-bbs2-0109" title="DuffyJM , AlAhwanyH , BhattacharyaS , ColluraB , CurtisC , EversJL , et al, Core Outcome Measure for Infertility Trials (COMMIT) initiative. Developing a core outcome set for future infertility research: an international consensus development study. Human Reproduction2020;35(12):2725–34. [DOI: https://doi.org/10.1093/humrep/deaa241]">Duffy 2020</a>.  </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010287-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010287-sec-0008"></div> <div class="table" id="CD010287-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Letrozole with or without adjuncts compared to SERMs with or without adjuncts followed by timed intercourse for infertile women with polycystic ovary syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Letrozole with or without adjuncts compared to SERMs with or without adjuncts followed by timed intercourse for infertile women with polycystic ovary syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> infertile women with polycystic ovary syndrome<br/><b>Setting:</b> (fertility) clinics or outpatient settings<br/><b>Intervention:</b> letrozole with or without adjuncts followed by timed intercourse<br/><b>Comparison:</b> SERMs (clomiphene citrate) with or without adjuncts followed by timed intercourse </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with SERMs with or without adjuncts</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with letrozole with or without adjuncts</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live birth rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>307 per 1000<br/>(265 to 352) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.72<br/>(1.40 to 2.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2060<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ovarian hyperstimulation syndrome rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/>(5 to 5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RD −0.00<br/>(−0.01 to 0.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1848<br/>(10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pregnancy rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>242 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>350 per 1000<br/>(316 to 387) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.69<br/>(1.45 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3321<br/>(23 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miscarriage rate per pregnancy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>252 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000<br/>(182 to 307) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.94<br/>(0.66 to 1.32) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>736<br/>(15 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiple pregnancy rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000<br/>(9 to 28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.74<br/>(0.42 to 1.32) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2247<br/>(14 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the mean risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>RD:</b> risk difference; <b>RCT</b>: randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD010287-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Letrozole compared to laparoscopic ovarian drilling for infertile women with polycystic ovary syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Letrozole compared to laparoscopic ovarian drilling compared to placebo for infertile women with polycystic ovary syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> infertile women with polycystic ovary syndrome<br/><b>Setting:</b> (fertility) clinics or outpatient settings<br/><b>Intervention:</b> letrozole with or without adjuncts followed by timed intercourse<br/><b>Comparison:</b> laparoscopic ovarian drilling (LOD) followed by timed intercourse </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with LOD</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with letrozole</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live birth rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>229 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>380 per 1000<br/>(227 to 561) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 2.07<br/>(0.99 to 4.32) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low<sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ovarian hyperstimulation syndrome rate</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No trials reported on this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pregnancy rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1000<br/>(279 to 482) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.47<br/>(0.95 to 2.28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>376<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miscarriage rate per pregnancy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>151 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>104 per 1000<br/>(38 to 254) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.65<br/>(0.22 to 1.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiple pregnancy rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 3.00<br/>(0.12 to 74.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low<sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>RCT</b>: randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Insufficient data to allow judgement of risk of bias in some trials ‐ downgraded one level for serious risk of bias.<br/><sup>b</sup>There is insufficient data to determine if there is a difference as opposed to no evidence of a difference ‐ downgraded one level for imprecision.<br/><sup>c</sup>Analysis is based on only one trial ‐ downgraded one additional level for imprecision.<br/>  </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010287-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010287-sec-0009"></div> <section id="CD010287-sec-0010"> <h3 class="title" id="CD010287-sec-0010">Description of the condition</h3> <p>Polycystic ovary syndrome (PCOS) is the most common cause of infrequent periods (oligomenorrhoea) and absence of periods (amenorrhoea), affecting about 5% to 20% of women worldwide in their fertile years (<a href="./references#CD010287-bbs2-0101" title="Abu HashimH . Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome: an evidence-based approach. Archives of Gynecology and Obstetrics2012;285(6):1737-45.">Abu 2012</a>; <a href="./references#CD010287-bbs2-0120" title="LiznevaD , SuturinaL , WalkerW , BraktaS , Gavrilova-JordanL , AzzizR . Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility2016;106(1):6-15. [DOI: 10.1016/j.fertnstert.2016.05.003]">Lizneva 2016</a>). Many of these women are infertile, but for most of them it just takes longer to become pregnant naturally and only a small percentage need fertility treatment. </p> <p>The mechanisms causing PCOS are very complex and the exact pathogenesis remains unknown, but some of the symptoms are believed to be caused by abnormal levels of the pituitary hormone, luteinising hormone (LH) and of the male hormones (androgens) which interfere with the normal function of the ovaries (<a href="./references#CD010287-bbs2-0102" title="AzzizR , CarminaE , DewaillyD , Diamanti-KandarakisE , Escobar-MorrealeHF , FutterweitW , et al, Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. Journal of Clinical Endocrinology and Metabolism2006;91(11):4237-45.">Azziz 2006</a>). </p> <p>The diagnosis can be made based on the 'Rotterdam Criteria 2003', jointly proposed by the European Society for Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) (<a href="./references#CD010287-bbs2-0128" title="Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction2004;19(1):41.">Rotterdam 2003</a>). The woman must have two of the following three criteria to be diagnosed with PCOS. </p> <p> <ul id="CD010287-list-0001"> <li> <p>Oligoovulation (infrequent ovulation) or anovulation (absence of ovulation), or both</p> </li> <li> <p>High male hormone levels (hyperandrogenism) diagnosed either clinically (excessive hair growth, hirsutism) or biochemically (raised serum testosterone levels) </p> </li> <li> <p>Ovaries which appear to be polycystic on vaginal sonogram, defined by the presence of 12 or more antral follicles in an ovary or an ovarian volume of more than 10 mL. Antral follicles are defined as measuring between 2 mm and 9 mm in diameter. </p> </li> </ul> </p> <p>Other definitions of PCOS include the National Institutes of Health Criteria (NIH), defined in 1990. They included only the presence of clinical and/or biochemical hyperandrogenism and oligo/amenorrhoea anovulation (<a href="./references#CD010287-bbs2-0136" title="ZawadskiJK , DunaifA . Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. Boston: Blackwell Scientific Publications1992:377-84.">Zawadski 1992</a>). The Androgen Excess Society (AES) defined PCOS as hyperandrogenism with ovarian dysfunction or polycystic ovaries (<a href="./references#CD010287-bbs2-0102" title="AzzizR , CarminaE , DewaillyD , Diamanti-KandarakisE , Escobar-MorrealeHF , FutterweitW , et al, Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. Journal of Clinical Endocrinology and Metabolism2006;91(11):4237-45.">Azziz 2006</a>). Based on the definition, the phenotype of women identified with PCOS can be very different, as could be the morbidity and hence the success of treatment (<a href="./references#CD010287-bbs2-0120" title="LiznevaD , SuturinaL , WalkerW , BraktaS , Gavrilova-JordanL , AzzizR . Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility2016;106(1):6-15. [DOI: 10.1016/j.fertnstert.2016.05.003]">Lizneva 2016</a>).  </p> </section> <section id="CD010287-sec-0011"> <h3 class="title" id="CD010287-sec-0011">Description of the intervention</h3> <p>There are many possible options for treatment of infertility in women with anovulatory PCOS. </p> <p>Clomiphene citrate (CC) is a selective oestrogen receptor modulator (SERM), and is the most common medication used for treating the condition. It was first introduced in 1960 for treatment of World Health Organization (WHO) type II anovulation (a type of infertility where hormone levels stay normal) in infertile women, and has been the first‐line treatment ever since. CC is given orally and is relatively safe and inexpensive, but there are also adverse effects associated with it, such as negative changes in endometrium and cervical mucus due to the down‐regulation of oestrogen receptors that might impair implantation after successful induction of ovulation (<a href="./references#CD010287-bbs2-0106" title="CasperRF , MitwallyMF . Review: aromatase inhibitors for ovulation induction. Journal of Clinical Endocrinology and Metabolism2006;91(3):760-71.">Casper 2006</a>). </p> <p>Aromatase inhibitors (AIs) are a newer class of drugs that were introduced for ovulation induction in 2001 by Mitwally and Casper (<a href="./references#CD010287-bbs2-0123" title="MitwallyMF , CasperRF . Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertility and Sterility2001;75(2):305-9.">Mitwally 2001</a>). Since about 2001, data from many clinical trials have been collected and there is evidence that the AI, letrozole, might be as effective as CC, but the outcome data vary. AIs are administered orally, but due to their short half‐life elimination time of 48 hours, there are fewer adverse effects on oestrogen target tissues such as the endometrium and cervix compared with CCs (<a href="./references#CD010287-bbs2-0055" title="BaruahJ , RoyKK , RahmanSM , KumarS , SharmaJB , KarmakarD . Endometrial effects of letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery Doppler. Archives of Gynecology &amp; Obstetrics2009;279(3):311-14. ">Baruah 2009</a>; <a href="./references#CD010287-bbs2-0117" title="JirgePR , PatilRS . Comparison of endocrine and ultrasound profiles during ovulation induction with clomiphene citrate and letrozole in ovulatory volunteer women. Fertility and Sterility2010;93(1):174-83.">Jirge 2010</a>; <a href="./references#CD010287-bbs2-0129" title="SamaniFG , FarzadiL , NezamiN , TarzamniMK , SoleimaniF . Endometrial and follicular development following letrozole intervention in unexplained infertile patients failed to get pregnant with clomiphene citrate. Archives of Gynecology and Obstetrics2009;280(2):201-5.">Samani 2009</a>). Despite evidence of effectiveness and safety in well‐designed large randomised controlled trials (RCTs), letrozole is still used off‐label for ovulation induction, since it has not been approved by the US Food and Drug Administration (FDA) for this indication (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>). A 2005 study (<a href="./references#CD010287-bbs2-0104" title="BiljanMM , HemmingsR , BrassardN . The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertility and Sterility2005;84(Suppl 1):s95.">Biljan 2005</a>), including 150 babies, raised some concerns about the teratogenicity of letrozole, but there were major methodological flaws in this study, as the intervention group was not well controlled. Two other large trials, including 911 and 470 infants respectively, compared the use of letrozole to CC in spontaneously‐conceiving women. Both reported no higher levels of minor or major congenital malformations or cardiac abnormalities in newborns after use of letrozole for ovulation induction (<a href="./references#CD010287-bbs2-0112" title="FormanR , GillS , MorettiM , TulandiT , KorenG , CasperR . Fetal safety of letrozole and clomiphene citrate for ovulation induction. Journal of Obstetrics and Gynaecology Canada2007;29(8):668.">Forman 2007</a>; <a href="./references#CD010287-bbs2-0132" title="TulandiT , MartinJ , Al-FadhliR , KabliN , FormanR , HitkariJ , et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertility and Sterility2006;85(6):1761-5.">Tulandi 2006</a>). </p> <p>Due to the short half‐life elimination time of letrozole, it should be completely cleared out of the system before implantation takes place. Some clinicians recommend testing the blood levels of beta‐human chorionic gonadotropin (ß‐hCG) prior to treatment with letrozole to exclude pregnancy (<a href="./references#CD010287-bbs2-0107" title="CasperRF , MitwallyMF . Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clinical Obstetrics and Gynaecology2011;54(4):685-95.">Casper 2011</a>). CC and AIs are usually both given for 5 days, starting on day 3 of the cycle. The dose for CC ranges from 50 mg to 150 mg a day, and for letrozole from 2.5 mg to 7.5 mg a day (<a href="./references#CD010287-bbs2-0118" title="LeeVC , LedgerW . Aromatase inhibitors for ovulation induction and ovarian stimulation. Clinical Endocrinology2011;74(5):537-46.">Lee 2011</a>). </p> <p>Since many women with PCOS experience insulin resistance or impaired glucose tolerance, metformin and other insulin‐sensitising agents were thought to be a superior drug for treatment of ovulation induction (<a href="./references#CD010287-bbs2-0133" title="VelázquezE , AcostaA , MendozaSG . Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstetrics and Gynecology1997;90(3):392-5.">Velázquez 1997</a>). However, the latest version of the Cochrane Review on oral agents for ovulation induction concludes that the use of metformin and other insulin‐sensitising agents as an adjunct is limited, and might be favourable only in women who are resistant to CC alone (<a href="./references#CD010287-bbs2-0105" title="BrownJ , FarquharC . Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database of Systematic Reviews2016, Issue 12. Art. No: CD002249. [DOI: 10.1002/14651858.CD002249.pub5]">Brown 2016</a>). </p> <p>Human menopausal gonadotropins (hMGs) were introduced into clinical practice in 1961 for ovulation induction. They exert a central role in ovulation induction in CC‐resistant infertile normogonadotropic anovulatory women (<a href="./references#CD010287-bbs2-0121" title="LunenfeldB . Historical perspectives in gonadotrophin therapy. Human Reproduction Update2004;10(6):453-67.">Lunenfeld 2004</a>). However, women with PCOS are at particular risk for complications such as ovarian hyperstimulation syndrome (OHSS) and multiple pregnancies. Ovarian hyperstimulation syndrome is a rare complication that can occur in women taking medication to stimulate egg growth and ovulation induction. The pathophysiology is not completely understood, but high levels of vascular endothelial growth factor (VEGF), secreted from many stimulated follicles under the prolonged effect of hCG, lead to a capillary leak and a fluid shift into the third space. This can result in ascites and hypovolaemia with subsequent circulatory, respiratory and renal problems (<a href="./references#CD010287-bbs2-0131" title="SoaresSR , GomezR , SimonC , Garcia-VelascoJA , PellicerA . Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Human Reproduction Update2008;14:321-33. [DOI: https://doi.org/10.1093/humupd/dmn008]">Soares 2008</a>).  </p> <p>A low‐dose step‐up protocol was introduced to reach the follicle stimulating hormone (FSH) threshold gradually in order to minimise the risks of OHSS and multiple pregnancies (<a href="./references#CD010287-bbs2-0135" title="WhiteDM , PolsonDW , KiddyD , SagleP , WatsonH , Gilling-SmithC , et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. Journal of Clinical Endocrinology and Metabolism1996;81(11):3821-4.">White 1996</a>). The use of FSH for ovulation induction in women with PCOS appears to be safe and effective (<a href="./references#CD010287-bbs2-0116" title="HomburgR , HendriksML , KönigTE , AndersonRA , BalenAH , BrincatM , et al. Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Human Reproduction2011;27(2):468-73.">Homburg 2011</a>). </p> <p>For all the above‐mentioned drugs for ovulation induction, follicular growth should be monitored during a stimulation cycle to reassure effectiveness and also to minimise the occurrence of adverse events, such as multiple pregnancy (<a href="./references#CD010287-bbs2-0134" title="Von HofeJ , Wright BatesG . Ovulation Induction. Obstetrics and Gynecoly Clinics of North America2015;42:27-37.">Von Hofe 2015</a>).  </p> <p>Finally, another possible option for ovulation induction in cases of CC resistance is laparoscopic ovarian diathermy (or drilling, LOD), during which the damaging of localised areas in the ovarian cortex and stroma seems to have similar success rates compared with gonadotropin therapy (<a href="./references#CD010287-bbs2-0110" title="FarquharCM , WilliamsonK , GudexG , JohnsonNP , GarlandJ , SadlerL . A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertility and Sterility2002;78(2):404.">Farquhar 2002</a>). It is not fully understood how the partial destruction of the ovary results in follicle development and ovulation induction (<a href="./references#CD010287-bbs2-0111" title="FarquharC , BrownJ , MarjoribanksJ . Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database of Systematic Reviews2012, Issue 6. Art. No: CD001122. [DOI: 10.1002/14651858.CD001122.pub4]">Farquhar 2012</a>), however, long‐term outcomes of a study with 8 to 12 years of follow‐up indicate that LOD is safe and effective (<a href="./references#CD010287-bbs2-0124" title="NahuisMJ , KoseN , BayramN , Van DesselHJ , BraatDD , HamiltonCJ , et al. Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins. Human Reproduction2011;26(7):1889-1904.">Nahuis 2011</a>). </p> </section> <section id="CD010287-sec-0012"> <h3 class="title" id="CD010287-sec-0012">How the intervention might work</h3> <p>AIs down‐regulate the production of oestrogen by inhibiting the cytochrome P450 isoenzymes 2A6 and 2C19 of the aromatase enzyme complex (<a href="./references#CD010287-bbs2-0108" title="ColePA , RobinsonCH . Mechanism and inhibition of cytochrome P-450 aromatase. Journal of Medical Chemistry1990;33(11):2933-44.">Cole 1990</a>). They inhibit the negative feedback loop of oestrogen in the hypothalamus, and result in stronger gonadotropin‐releasing hormone (GnRH) pulses. The elevated levels of GnRH stimulate the pituitary gland to produce more FSH, which induces development of follicles in the ovaries. Because AIs do not deplete oestrogen receptors, in contrast to CC, the central feedback mechanism remains intact, and as the dominant follicle grows and oestrogen levels rise, normal negative feedback occurs centrally. This results in suppression of FSH and the smaller‐growing follicles will undergo atresia, leading to a single dominant follicle and mono‐ovulation (ovulation of a single egg) in most cases (<a href="./references#CD010287-bbs2-0106" title="CasperRF , MitwallyMF . Review: aromatase inhibitors for ovulation induction. Journal of Clinical Endocrinology and Metabolism2006;91(3):760-71.">Casper 2006</a>; <a href="./references#CD010287-bbs2-0118" title="LeeVC , LedgerW . Aromatase inhibitors for ovulation induction and ovarian stimulation. Clinical Endocrinology2011;74(5):537-46.">Lee 2011</a>). Therefore, by leaving the central mechanism intact, the AIs might lower the risk of high‐multiple ovulation and OHSS compared to CC. </p> </section> <section id="CD010287-sec-0013"> <h3 class="title" id="CD010287-sec-0013">Why it is important to do this review</h3> <p>Because evidence for and against the effectiveness and safety of AIs has fluctuated over the last decade, and new data based on recent RCTs have become available, an update of the existing Cochrane Review was necessary to provide up‐to‐date information for daily practice. </p> <p>This review evaluates the effectiveness and safety of AIs compared to other agents for ovulation induction or laparoscopic ovarian drilling, to provide evidence about whether or not AIs should be used in infertile women with PCOS who are trying to conceive. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010287-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010287-sec-0014"></div> <p>To evaluate the effectiveness and safety of AIs (letrozole) (with or without adjuncts) compared to SERMs (with or without adjuncts) for infertile women with anovulatory PCOS for ovulation induction followed by timed intercourse or intrauterine insemination. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010287-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010287-sec-0015"></div> <section id="CD010287-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010287-sec-0017"> <h4 class="title">Types of studies</h4> <p>We considered randomised controlled trials (RCTs) for inclusion in the review. We excluded cross‐over trials unless phase one data were available separately. </p> </section> <section id="CD010287-sec-0018"> <h4 class="title">Types of participants</h4> <p>Women of reproductive age with anovulatory PCOS (WHO type II anovulation in women with normogonadotropic normoestrogenic anovulation), diagnosed according to the Rotterdam Criteria (<a href="./references#CD010287-bbs2-0128" title="Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction2004;19(1):41.">Rotterdam 2003</a>), the NIH consensus criteria (<a href="./references#CD010287-bbs2-0136" title="ZawadskiJK , DunaifA . Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. Boston: Blackwell Scientific Publications1992:377-84.">Zawadski 1992</a>), or the AES criteria (<a href="./references#CD010287-bbs2-0103" title="AzzizR , CarminaE , DewaillyD , Diamanti-KandarakisE , Escobar-MorrealeHF , FutterweitW , et al, Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility2009;91(2):456. [PMID: 18950759]">Azziz 2009</a>). </p> <section id="CD010287-sec-0019"> <h5 class="title">Exclusion criteria</h5> <p>We excluded RCTs of women with hyperprolactinaemia or Cushing’s syndrome, or both. We also excluded trials covering women with WHO type I anovulation (hypogonadotropic hypogonadal anovulation). Women in this group have amenorrhoea, low or low‐normal serum FSH concentrations and low serum estradiol concentrations due to decreased hypothalamic secretion of GnRH or pituitary unresponsiveness to GnRH. We excluded trials using methods other than ovulation induction followed by intercourse or intrauterine insemination, for example, in vitro fertilisation (IVF). </p> </section> </section> <section id="CD010287-sec-0020"> <h4 class="title">Types of interventions</h4> <p>We considered for inclusion AIs (letrozole) for ovulation induction, alone or in conjunction with medical adjuncts, e.g. metformin or FSH compared to SERMs with or without adjuncts followed by sexual intercourse or intrauterine insemination in women with anovulatory infertility.  </p> </section> <section id="CD010287-sec-0021"> <h4 class="title">Types of outcome measures</h4> <section id="CD010287-sec-0022"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0023"> <h6 class="title">Effectiveness</h6> <p> <ul id="CD010287-list-0002"> <li> <p>Live birth rate, defined as delivery of a live foetus after 20 completed weeks of gestational age </p> </li> </ul> </p> </section> <section id="CD010287-sec-0024"> <h6 class="title">Adverse events</h6> <p> <ul id="CD010287-list-0003"> <li> <p>OHSS rate, as defined by the trial authors</p> </li> </ul> </p> </section> </section> <section id="CD010287-sec-0025"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010287-list-0004"> <li> <p>Clinical pregnancy rate, defined as viable intrauterine pregnancy confirmed by ultrasound</p> </li> <li> <p>Miscarriage rate per woman, defined as the involuntary loss of a clinical pregnancy before 20 weeks of gestation, including partial loss of a multiple pregnancy </p> </li> <li> <p>Miscarriage rate per pregnancy, defined as the involuntary loss of a clinical pregnancy before 20 weeks of gestation, including partial loss of a multiple pregnancy </p> </li> <li> <p>Multiple pregnancy rate, defined as more than one intrauterine pregnancy, confirmed by ultrasound or delivery </p> </li> </ul> </p> </section> </section> </section> <section id="CD010287-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all published and unpublished RCTs investigating the use of AIs for ovulation induction in anovulatory women with PCOS in consultation with the Cochrane Gynaecology and Fertility (CGF) Information Specialist. We used both indexed and free‐text terms, and applied no language or date restrictions. </p> <section id="CD010287-sec-0027"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases.</p> <p> <ul id="CD010287-list-0005"> <li> <p>The Cochrane Gynaecology and Fertility (CGF) Specialised Register, ProCite platform, searched from inception to 4 November 2021 (<a href="./appendices#CD010287-sec-0155">Appendix 1</a>). </p> </li> <li> <p>CENTRAL, via the Cochrane Register of Studies Online (CRSO), Web platform, searched from inception to 4 November 2021 (<a href="./appendices#CD010287-sec-0156">Appendix 2</a>). </p> </li> <li> <p>MEDLINE, Ovid platform, searched from 1946 to 4 November 2021 (<a href="./appendices#CD010287-sec-0157">Appendix 3</a>). </p> </li> <li> <p>Embase, Ovid platform, searched from 1980 to 4 November 2021 (<a href="./appendices#CD010287-sec-0158">Appendix 4</a>). </p> </li> <li> <p>PsycINFO, Ovid platform, searched from 1806 to 4 November 2021 (<a href="./appendices#CD010287-sec-0159">Appendix 5</a>). </p> </li> </ul> </p> <p>We combined the MEDLINE search with the Cochrane highly‐sensitive search strategy for identifying randomised trials which appears in the <i>Cochrane Handbook for Systematic Reviews of Interventions (Cochrane Handbook)</i> (Version 6.2 chapter 4, 4.4.7) (<a href="./references#CD010287-bbs2-0119" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Lefebvre 2021</a>). We combined the Embase search with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<a href="https://www.sign.ac.uk/what-we-do/methodology/search-filters/" target="_blank">www.sign.ac.uk/what-we-do/methodology/search-filters</a>). </p> </section> <section id="CD010287-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We checked the references of relevant systematic reviews and RCTs obtained by the search, and contacted experts in the field and manufacturers of AIs, to pick up any additional, relevant trials. </p> <p>We also searched the following up to November 2021 for grey literature of additional trials that had not been indexed in major databases. </p> <p> <ul id="CD010287-list-0006"> <li> <p>International trial registers</p> <ul id="CD010287-list-0007"> <li> <p>ClinicalTrials database, a service of the US National Institutes of Health (<a href="http://clinicaltrials.gov/ct2/home" target="_blank">clinicaltrials.gov/ct2/home</a>) </p> </li> <li> <p>World Health Organization International Trials Registry Platform search portal (<a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">www.who.int/trialsearch/Default.aspx</a>) </p> </li> </ul> </li> <li> <p>Google Scholar</p> </li> </ul> </p> </section> </section> <section id="CD010287-sec-0029"> <h3 class="title" id="CD010287-sec-0029">Data collection and analysis</h3> <p>We conducted data collection and analysis in accordance with the <i>Cochrane Handbook</i> (<a href="./references#CD010287-bbs2-0115" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). </p> <section id="CD010287-sec-0030"> <h4 class="title">Selection of studies</h4> <p>For this update of the review, two review authors (SF and QL) independently selected the trials to be included, in accordance with the aforementioned criteria. We excluded trials from the review if they made comparisons other than those specified above. Studies from non‐English language journals were translated if necessary. If a trial was published more than once, we only included the most complete and up‐to‐date data. We contacted authors of primary studies if papers did not contain enough information to enable an accurate assessment of eligibility for inclusion. We provide a list of excluded studies, showing the reasons for exclusion in the <a href="./references#CD010287-sec-0173" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD010287-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>For this update of the review, two review authors (SF and QL) independently extracted the data, resolving any disagreements by recourse to a third party. We used a data extraction form designed and piloted by the review authors. All data collected for our analyses were dichotomous. If studies had multiple publications, we included only the main trial report. The review authors contacted trial investigators to resolve any data queries, as required. </p> </section> <section id="CD010287-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the included trials for risks of bias, using the Cochrane RoB 1 tool (<a href="./references#CD010287-bbs2-0114" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>). We evaluated the following seven domains of possible bias. </p> <p> <ul id="CD010287-list-0008"> <li> <p>Random sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants and personnel</p> </li> <li> <p>Blinding of outcome assessment</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective reporting</p> </li> <li> <p>Other potential bias</p> </li> </ul> </p> <p>We judged the different types of bias using the criteria from the <i>Cochrane Handbook</i> (<a href="./references#CD010287-bbs2-0114" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>). Two review authors (SF and SE) checked these domains of bias independently and rated them as being at high, low or unclear risk of bias. The assessments were compared and any disagreements resolved by consensus or by discussion with a third review author (CF). The conclusions are presented in the risk of bias table and were incorporated into the interpretation of the review findings by means of sensitivity analyses. </p> </section> <section id="CD010287-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <p>Where dichotomous data measures were used, we have expressed the results in the control and intervention groups of each trial as odds ratios (ORs) with 95% confidence intervals (CIs). For the very rare outcome, OHSS, we have used a risk difference (RD) analysis to allow CIs for the difference in percentage points. A RD approach was chosen over OR due to zero events in one or more trial arms. Based on the specified outcomes, there were no continuous data measures. </p> </section> <section id="CD010287-sec-0034"> <h4 class="title">Unit of analysis issues</h4> <p>The primary analysis was per woman randomised. We also analysed the secondary outcome of miscarriage rate per pregnancy. We contacted authors of trials that used cycles as the denominator rather than women, for additional information; if we could not obtain it, we did not include the trial in the analysis. If there were multiple cycles, the unit of analysis remained as the woman randomised. We used only the first phase of cross‐over trials in the analysis, as successful treatment prevents a cross‐over. We treated multiple live births as one event. </p> </section> <section id="CD010287-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>If data were missing from included studies, we contacted the investigators to request the relevant missing data. If this was not possible, we imputed individual values for the primary and secondary outcomes. In participants without a reported outcome, we assumed that live births had not occurred. For other outcomes, we analysed only the available data. We subjected any imputation to sensitivity analysis. We analysed the data on an intention‐to‐treat (ITT) basis, as far as possible. </p> </section> <section id="CD010287-sec-0036"> <h4 class="title">Assessment of heterogeneity</h4> <p>We tested the results of the included trials for heterogeneity by measuring the scatter in the data points on the graph and the overlap in their CIs. We used the I<sup>2</sup> statistic, which describes the percentage of total variation across the trials that is due to heterogeneity rather than to chance (<a href="./references#CD010287-bbs2-0115" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). The values of the I<sup>2</sup> statistic lie between 0% (no heterogeneity) and 100% (extreme heterogeneity). We take values above 50% to indicate moderate heterogeneity and we explored them within sensitivity and subgroup analyses. </p> </section> <section id="CD010287-sec-0037"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty of detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible trials and by being alert to duplication of data<i>.</i> We compared all outcome measures stated in the Methods section to the outcomes reported in the Results section, to ensure comparability. If there were more than 10 trials included in a comparison, we produced a funnel plot to test for reporting bias. </p> </section> <section id="CD010287-sec-0038"> <h4 class="title">Data synthesis</h4> <p>We used a fixed‐effect model to combine the data from the primary studies if they were sufficiently similar. We conducted statistical analysis with Review Manager 5 (<a href="./references#CD010287-bbs2-0126" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>), in accordance with the guidelines for statistical analysis developed by Cochrane (<a href="./references#CD010287-bbs2-0115" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). </p> <p>Our comparisons were:</p> <p> <ul id="CD010287-list-0009"> <li> <p>letrozole compared to placebo;</p> </li> <li> <p>letrozole compared to SERMs with or without adjuncts followed by timed intercourse;</p> </li> <li> <p>letrozole compared to SERMs with or without adjuncts followed by intrauterine insemination;</p> </li> <li> <p>letrozole compared to LOD with or without adjuncts;</p> </li> <li> <p>letrozole compared to FSH;</p> </li> <li> <p>letrozole compared to anastrozole;</p> </li> <li> <p>letrozole compared to berberine;</p> </li> <li> <p>comparison of different administration protocols of letrozole;</p> </li> <li> <p>dosage studies of letrozole.</p> </li> </ul> </p> <p>Increases in the odds of an outcome, either beneficial (e.g. live birth rate) or detrimental (e.g. OHSS rate) are shown in the forest plots of the meta‐analysis to the right of the centre line.<br/>  </p> </section> <section id="CD010287-sec-0039"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed subgroup analysis for primary outcomes only, to evaluate the evidence for a trial population with an average body mass index (BMI) &gt; 25 compared to women with an average BMI &lt; 25 within their trial group. We conducted a further subgroup analysis comparing women with no previous treatment for ovulation induction to women that were CC‐resistant. We intended to perform subgroup analyses on other parameters, such as the age of the woman, the duration of infertility and the duration and drug dosages, but this was not possible due to the lack of data.   </p> </section> <section id="CD010287-sec-0040"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted a sensitivity analysis for the primary outcomes to evaluate whether the conclusions are robust to arbitrary decisions made about the eligibility and analysis of trials. This analysis includes consideration of whether the review conclusions would have differed if: </p> <p> <ul id="CD010287-list-0010"> <li> <p>eligibility was restricted to trials without high or unclear risk of bias;</p> </li> <li> <p>we had used a random‐effects model;</p> </li> <li> <p>we had implemented alternative imputation strategies;</p> </li> <li> <p>the summary effect measure had been the risk ratio (RR) instead of the OR.</p> </li> </ul> </p> </section> <section id="CD010287-sec-0041"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We generated summary of findings tables using GRADE (<a href="./references#CD010287-bbs2-0130" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>) and GRADEpro GDT software (<a href="./references#CD010287-bbs2-0113" title="GRADEpro GDT. Version accessed prior to 26 September 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>), to evaluate the overall certainty of the body of evidence for: aromatase inhibitors (letrozole) with or without adjuncts compared to SERMs, with or without adjuncts (summary of findings table 1); and aromatase inhibitors (letrozole) compared to LOD (summary of findings table 2). GRADE criteria includes: trial limitations (risk of bias), consistency of effect, imprecision, indirectness and publication bias. Judgements about evidence certainty (high, moderate, low or very low) were justified, documented and incorporated into the reporting of results for each outcome. Two review authors independently evaluated the overall certainty of the evidence for the main outcomes of the review (live birth rate, OHSS rate, clinical pregnancy rate, miscarriage rate per pregnancy, multiple pregnancy rate). There are no summary of findings tables for the remaining comparisons of the review, because we considered them less clinically important. The results of these comparisons are discussed within the text of the review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010287-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010287-sec-0042"></div> <section id="CD010287-sec-0043"> <h3 class="title">Description of studies</h3> <section id="CD010287-sec-0044"> <h4 class="title">Results of the search</h4> <p>The previous version of this review included 42 trials. The searches for the 2021 review update resulted in the retrieval of 25 full‐text papers (<a href="#CD010287-fig-0001">Figure 1</a>). We included five new trials (<a href="./references#CD010287-sec-0172" title="">Characteristics of included studies</a>). We excluded four new trials (<a href="./references#CD010287-sec-0173" title="">Characteristics of excluded studies</a>). Seven new trials are awaiting classification (<a href="./references#CD010287-sec-0174" title="">Characteristics of studies awaiting classification</a>); we have contacted their authors and still await a response. Six new trials are ongoing (<a href="./references#CD010287-sec-0175" title="">Characteristics of ongoing studies</a>). We have moved four trials from included to excluded (<a href="./references#CD010287-bbs2-0042" title="Abu HashimH , ShokeirT , BadawyA . RETRACTED: Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. Fertility and Sterility2010;94(4):1405-9. 8527270">Abu Hashim 2010</a>; <a href="./references#CD010287-bbs2-0051" title="BadawyA , MosbahA , ShadyM . RETRACTED: Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial. Fertility and Sterility2008;89(5):1209-12. ">Badawy 2008</a>; <a href="./references#CD010287-bbs2-0052" title="BadawyA , MosbahA , TharwatA , EidM . EXPRESSION OF CONCERN: Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol. Fertility and Sterility2009;92(1):236-9. ">Badawy 2009a</a>; <a href="./references#CD010287-bbs2-0053" title="BadawyA , Abdel AalI , AbulattaM . RETRACTED: Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertility and Sterility2009;92(3):849-52. ">Badawy 2009b</a>), and two trials from included to awaiting classification due to concerns about validity of the trial data (<a href="./references#CD010287-bbs2-0081" title="Abu HashimH , MashalyAM , BadawyA . Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. Archives of Gynecology and Obstetrics2010;282(5):567-71. ">Abu Hashim 2010a</a>; <a href="./references#CD010287-bbs2-0080" title="AbdellahMS . Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology and Obstetrics2011;113(3):218-21. ">Abdellah 2011</a>). The review update contains 41 included trials (<a href="#CD010287-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD010287-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram for update 2021" data-id="CD010287-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for update 2021</p> </div> </div> </div> </section> <section id="CD010287-sec-0045"> <h4 class="title">Included studies</h4> <section id="CD010287-sec-0046"> <h5 class="title">Study design and setting</h5> <p>We include 41 parallel‐designed RCTs in this 2021 updated review.</p> <p>The trials were done in different parts of the world.</p> <p> <ul id="CD010287-list-0011"> <li> <p>China (<a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>; <a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>) </p> </li> <li> <p>Egypt (<a href="./references#CD010287-bbs2-0012" title="EL-GharibMN , MahfouzAE , FarahatMA . Comparison of letrozole versus tamoxifen effects in clomiphene citrate resistant women with polycystic ovarian syndrome. Journal of Reproduction and Infertility2015;16(1):30-5. ">El‐Gharib 2015</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0011" title="ElgaforIA . Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2013;288(1):119-23. [DOI: 10.1007/s00404-013-2714-2]">Elgafor 2013</a>; <a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0019" title="HendawySF , SamahaHE , ElkholyMF . Letrozole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clinical Medicine Insights: Reproductive Health2011;5:11-16. ">Hendawy 2011</a>; <a href="./references#CD010287-bbs2-0020" title="IbrahimMH , TawficM , HassanMM , SedkyOH . Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate. Middle East Fertility Society Journal2017;22(4):251-4. ">Ibrahim 2017</a>; <a href="./references#CD010287-bbs2-0026" title="MoussaAA , TorkyH , DiefO , ElwahedAA , SennaHA . The effect of clomiphene citrate versus tamoxifen versus letrozole on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Medica International2016;3(2):88-92. ">Moussa 2016</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>) </p> </li> <li> <p>India (<a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0036" title="Sheikh-El-Arab ElsedeekM , ElmaghrabyHA . Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal2011;16(2):125-30. ">Sh‐El‐Arab Elsedeek 2011</a>) </p> </li> <li> <p>Iraq (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>; <a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>) </p> </li> <li> <p>Iran (<a href="./references#CD010287-bbs2-0007" title="BehnoudN , FarzanehF , ErshadiS . The effect of clomiphene citrate versus letrozole on pregnancy rate in women with polycystic ovary syndrome: a randomized clinical trial. Crescent Journal of Medical and Biological Sciences2019;6(3):335-40. ">Behnoud 2019</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0017" title="GhomianN , KhosraviA , MousavifarN . A randomized clinical trial on comparing the cycle characteristics of two different initiation days of letrozole treatment in clomiphene citrate resistant PCOS patients in IUI cycles. International Journal of Fertility and Sterility2015;9(1):17-26. ">Ghomian 2015</a>; <a href="./references#CD010287-bbs2-0027" title="NajafiPZ , NoghabiSP , AfzaliN , MohammadzadehS . Comparing the effect of clomiphene citrate and letrozole on ovulation induction in infertile women with polycystic ovary syndrome. Journal of the Pakistan Medical Association2020;70(2):268-71. ">Najafi 2020</a> <a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>; <a href="./references#CD010287-bbs2-0040" title="ZareiA , ShabahramiTB , DadrasN . Effects of letrozole in prevention of premature luteinizing hormone (LH) surge in infertile women with clomiphene citrate resistant polycystic ovary syndrome (PCOS) undergoing intrauterine insemination. Galen Medical Journal2015;4(3):104-11. ">Zarei 2015</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>) </p> </li> <li> <p>Mexico (<a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>) </p> </li> <li> <p>Pakistan (<a href="./references#CD010287-bbs2-0003" title="AshfaqA , TahseenH , NoreenZ , AlamN . Clomiphene citrate vs letrozole in PCO's patient's for ovulation induction. Pakistan Journal of Medical and Health Sciences2018;12(2):781-3. ">Ashfaq 2018</a>) </p> </li> <li> <p>Turkey (<a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>) </p> </li> <li> <p>UK (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>) </p> </li> <li> <p>USA (<a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>) </p> </li> </ul> </p> <p>The following different settings recruited women into the trials.</p> <p> <ul id="CD010287-list-0012"> <li> <p>Not stated (<a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>) </p> </li> <li> <p>Subfertility clinic (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>; <a href="./references#CD010287-bbs2-0036" title="Sheikh-El-Arab ElsedeekM , ElmaghrabyHA . Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal2011;16(2):125-30. ">Sh‐El‐Arab Elsedeek 2011</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>) </p> </li> <li> <p>Outpatient clinic (<a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0012" title="EL-GharibMN , MahfouzAE , FarahatMA . Comparison of letrozole versus tamoxifen effects in clomiphene citrate resistant women with polycystic ovarian syndrome. Journal of Reproduction and Infertility2015;16(1):30-5. ">El‐Gharib 2015</a>; <a href="./references#CD010287-bbs2-0020" title="IbrahimMH , TawficM , HassanMM , SedkyOH . Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate. Middle East Fertility Society Journal2017;22(4):251-4. ">Ibrahim 2017</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>) </p> </li> <li> <p>Department of obstetrics and gynaecology (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>; <a href="./references#CD010287-bbs2-0003" title="AshfaqA , TahseenH , NoreenZ , AlamN . Clomiphene citrate vs letrozole in PCO's patient's for ovulation induction. Pakistan Journal of Medical and Health Sciences2018;12(2):781-3. ">Ashfaq 2018</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0011" title="ElgaforIA . Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2013;288(1):119-23. [DOI: 10.1007/s00404-013-2714-2]">Elgafor 2013</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>) </p> </li> <li> <p>Division of reproductive endocrinology (<a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>) </p> </li> <li> <p>Maternity and child hospital (<a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0040" title="ZareiA , ShabahramiTB , DadrasN . Effects of letrozole in prevention of premature luteinizing hormone (LH) surge in infertile women with clomiphene citrate resistant polycystic ovary syndrome (PCOS) undergoing intrauterine insemination. Galen Medical Journal2015;4(3):104-11. ">Zarei 2015</a>) </p> </li> <li> <p>University hospital (<a href="./references#CD010287-bbs2-0007" title="BehnoudN , FarzanehF , ErshadiS . The effect of clomiphene citrate versus letrozole on pregnancy rate in women with polycystic ovary syndrome: a randomized clinical trial. Crescent Journal of Medical and Biological Sciences2019;6(3):335-40. ">Behnoud 2019</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0017" title="GhomianN , KhosraviA , MousavifarN . A randomized clinical trial on comparing the cycle characteristics of two different initiation days of letrozole treatment in clomiphene citrate resistant PCOS patients in IUI cycles. International Journal of Fertility and Sterility2015;9(1):17-26. ">Ghomian 2015</a>; <a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0019" title="HendawySF , SamahaHE , ElkholyMF . Letrozole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clinical Medicine Insights: Reproductive Health2011;5:11-16. ">Hendawy 2011</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0026" title="MoussaAA , TorkyH , DiefO , ElwahedAA , SennaHA . The effect of clomiphene citrate versus tamoxifen versus letrozole on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Medica International2016;3(2):88-92. ">Moussa 2016</a>; <a href="./references#CD010287-bbs2-0027" title="NajafiPZ , NoghabiSP , AfzaliN , MohammadzadehS . Comparing the effect of clomiphene citrate and letrozole on ovulation induction in infertile women with polycystic ovary syndrome. Journal of the Pakistan Medical Association2020;70(2):268-71. ">Najafi 2020</a>; <a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>) </p> </li> <li> <p>Women's health institute (<a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>) </p> </li> </ul> </p> </section> <section id="CD010287-sec-0047"> <h5 class="title">Participants</h5> <p>The trials included 6522 women who were infertile due to anovulatory PCOS. The ages of the women ranged from 18 to 40 years. </p> </section> <section id="CD010287-sec-0048"> <h5 class="title">Interventions</h5> <p> <ul id="CD010287-list-0013"> <li> <p>2/41 trials compared letrozole to placebo (<a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>; <a href="./references#CD010287-bbs2-0040" title="ZareiA , ShabahramiTB , DadrasN . Effects of letrozole in prevention of premature luteinizing hormone (LH) surge in infertile women with clomiphene citrate resistant polycystic ovary syndrome (PCOS) undergoing intrauterine insemination. Galen Medical Journal2015;4(3):104-11. ">Zarei 2015</a>). </p> </li> <li> <p>28/41 trials compared letrozole to SERMs with or without adjuncts followed by intercourse (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0003" title="AshfaqA , TahseenH , NoreenZ , AlamN . Clomiphene citrate vs letrozole in PCO's patient's for ovulation induction. Pakistan Journal of Medical and Health Sciences2018;12(2):781-3. ">Ashfaq 2018</a>; <a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0007" title="BehnoudN , FarzanehF , ErshadiS . The effect of clomiphene citrate versus letrozole on pregnancy rate in women with polycystic ovary syndrome: a randomized clinical trial. Crescent Journal of Medical and Biological Sciences2019;6(3):335-40. ">Behnoud 2019</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0012" title="EL-GharibMN , MahfouzAE , FarahatMA . Comparison of letrozole versus tamoxifen effects in clomiphene citrate resistant women with polycystic ovarian syndrome. Journal of Reproduction and Infertility2015;16(1):30-5. ">El‐Gharib 2015</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0019" title="HendawySF , SamahaHE , ElkholyMF . Letrozole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clinical Medicine Insights: Reproductive Health2011;5:11-16. ">Hendawy 2011</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0026" title="MoussaAA , TorkyH , DiefO , ElwahedAA , SennaHA . The effect of clomiphene citrate versus tamoxifen versus letrozole on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Medica International2016;3(2):88-92. ">Moussa 2016</a>; <a href="./references#CD010287-bbs2-0027" title="NajafiPZ , NoghabiSP , AfzaliN , MohammadzadehS . Comparing the effect of clomiphene citrate and letrozole on ovulation induction in infertile women with polycystic ovary syndrome. Journal of the Pakistan Medical Association2020;70(2):268-71. ">Najafi 2020</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>; <a href="./references#CD010287-bbs2-0036" title="Sheikh-El-Arab ElsedeekM , ElmaghrabyHA . Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal2011;16(2):125-30. ">Sh‐El‐Arab Elsedeek 2011</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>). </p> </li> <li> <p>3/41 trials compared letrozole to SERMs with or without adjuncts followed by intrauterine insemination (<a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). </p> </li> <li> <p>3/41 trials compared letrozole to laparoscopic ovarian drilling (<a href="./references#CD010287-bbs2-0011" title="ElgaforIA . Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2013;288(1):119-23. [DOI: 10.1007/s00404-013-2714-2]">Elgafor 2013</a>; <a href="./references#CD010287-bbs2-0020" title="IbrahimMH , TawficM , HassanMM , SedkyOH . Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate. Middle East Fertility Society Journal2017;22(4):251-4. ">Ibrahim 2017</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>). </p> </li> <li> <p>1/41 trials compared letrozole to FSH (<a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>). </p> </li> <li> <p>1/41 trials compared letrozole to anastrozole (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>). </p> </li> <li> <p>1/41 trials compared letrozole to berberine (<a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>). </p> </li> <li> <p>1/41 trials compared different administration protocols of letrozole (<a href="./references#CD010287-bbs2-0017" title="GhomianN , KhosraviA , MousavifarN . A randomized clinical trial on comparing the cycle characteristics of two different initiation days of letrozole treatment in clomiphene citrate resistant PCOS patients in IUI cycles. International Journal of Fertility and Sterility2015;9(1):17-26. ">Ghomian 2015</a>). </p> </li> <li> <p>1/41 trials compared different doses of letrozole (<a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>). </p> </li> </ul> </p> <p>See <a href="./references#CD010287-sec-0172" title="">Characteristics of included studies</a>. </p> </section> <section id="CD010287-sec-0049"> <h5 class="title">Outcomes</h5> <p> <ul id="CD010287-list-0014"> <li> <p>14/41 trials reported live birth rate (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>; <a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>). </p> </li> <li> <p>17/41 trials reported OHSS rate (<a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>; <a href="./references#CD010287-bbs2-0040" title="ZareiA , ShabahramiTB , DadrasN . Effects of letrozole in prevention of premature luteinizing hormone (LH) surge in infertile women with clomiphene citrate resistant polycystic ovary syndrome (PCOS) undergoing intrauterine insemination. Galen Medical Journal2015;4(3):104-11. ">Zarei 2015</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). </p> </li> <li> <p>37/41 trials reported clinical pregnancy rate (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>; <a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0012" title="EL-GharibMN , MahfouzAE , FarahatMA . Comparison of letrozole versus tamoxifen effects in clomiphene citrate resistant women with polycystic ovarian syndrome. Journal of Reproduction and Infertility2015;16(1):30-5. ">El‐Gharib 2015</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0011" title="ElgaforIA . Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2013;288(1):119-23. [DOI: 10.1007/s00404-013-2714-2]">Elgafor 2013</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0017" title="GhomianN , KhosraviA , MousavifarN . A randomized clinical trial on comparing the cycle characteristics of two different initiation days of letrozole treatment in clomiphene citrate resistant PCOS patients in IUI cycles. International Journal of Fertility and Sterility2015;9(1):17-26. ">Ghomian 2015</a>; <a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0020" title="IbrahimMH , TawficM , HassanMM , SedkyOH . Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate. Middle East Fertility Society Journal2017;22(4):251-4. ">Ibrahim 2017</a>; <a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0026" title="MoussaAA , TorkyH , DiefO , ElwahedAA , SennaHA . The effect of clomiphene citrate versus tamoxifen versus letrozole on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Medica International2016;3(2):88-92. ">Moussa 2016</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>; <a href="./references#CD010287-bbs2-0036" title="Sheikh-El-Arab ElsedeekM , ElmaghrabyHA . Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal2011;16(2):125-30. ">Sh‐El‐Arab Elsedeek 2011</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>; <a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>; <a href="./references#CD010287-bbs2-0040" title="ZareiA , ShabahramiTB , DadrasN . Effects of letrozole in prevention of premature luteinizing hormone (LH) surge in infertile women with clomiphene citrate resistant polycystic ovary syndrome (PCOS) undergoing intrauterine insemination. Galen Medical Journal2015;4(3):104-11. ">Zarei 2015</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). </p> </li> <li> <p>25/41 trials reported miscarriage rate per woman and per pregnancy (<a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0011" title="ElgaforIA . Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2013;288(1):119-23. [DOI: 10.1007/s00404-013-2714-2]">Elgafor 2013</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0020" title="IbrahimMH , TawficM , HassanMM , SedkyOH . Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate. Middle East Fertility Society Journal2017;22(4):251-4. ">Ibrahim 2017</a>; <a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>; <a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>; <a href="./references#CD010287-bbs2-0040" title="ZareiA , ShabahramiTB , DadrasN . Effects of letrozole in prevention of premature luteinizing hormone (LH) surge in infertile women with clomiphene citrate resistant polycystic ovary syndrome (PCOS) undergoing intrauterine insemination. Galen Medical Journal2015;4(3):104-11. ">Zarei 2015</a>). </p> </li> <li> <p>25/41 trials reported multiple pregnancy rate (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>; <a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0019" title="HendawySF , SamahaHE , ElkholyMF . Letrozole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clinical Medicine Insights: Reproductive Health2011;5:11-16. ">Hendawy 2011</a> <a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0064" title="NCT00610077. An open, randomized, parallel-group, multicentric, comparative study of letrozole with clomiphene citrate for induction of ovulation in anovulatory infertility. clinicaltrials.gov/ct2/show/NCT00610077 (first received 7 February 2008). [NCT00610077]">NCT00610077</a>; <a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>; <a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>; <a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). </p> </li> </ul> </p> <p>See <a href="./references#CD010287-sec-0172" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD010287-sec-0050"> <h4 class="title">Excluded studies</h4> <p>We excluded 38 trials from the review. Eight of these were identified for the 2021 update (<a href="./references#CD010287-bbs2-0042" title="Abu HashimH , ShokeirT , BadawyA . RETRACTED: Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. Fertility and Sterility2010;94(4):1405-9. 8527270">Abu Hashim 2010</a>; <a href="./references#CD010287-bbs2-0045" title="Al-ObaidiMT , AliZH , Al-SaadiWI , Al-WasitiEA , Al-AubaidyH . Impact of letrozole versus clomiphene citrate on endometrial receptivity in Iraqi women with polycystic ovarian syndrome. Journal of Clinical Pharmacy and Therapeutics2019;44:618-22. ">Al‐Obaidi 2018</a>; <a href="./references#CD010287-bbs2-0051" title="BadawyA , MosbahA , ShadyM . RETRACTED: Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial. Fertility and Sterility2008;89(5):1209-12. ">Badawy 2008</a>; <a href="./references#CD010287-bbs2-0052" title="BadawyA , MosbahA , TharwatA , EidM . EXPRESSION OF CONCERN: Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol. Fertility and Sterility2009;92(1):236-9. ">Badawy 2009a</a>; <a href="./references#CD010287-bbs2-0053" title="BadawyA , Abdel AalI , AbulattaM . RETRACTED: Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertility and Sterility2009;92(3):849-52. ">Badawy 2009b</a>; <a href="./references#CD010287-bbs2-0058" title="HuangS , WangR , LiR , YanH , LiN , WangH , et al. Intrauterine insemination (IUI) with or without letrozole for unexplained or mild male factor infertility: a randomized pilot study. Human Reproduction2019;34(Suppl 1):i149. [https://clinicaltrials.gov/show/NCT03455426]">Huang 2019</a>; <a href="./references#CD010287-bbs2-0070" title="AbbasAM . Letrozole in clomiphene resistant infertile women with polycystic ovarian syndrome. clinicaltrials.gov/ct2/show/NCT03135301 (first received 1 May 2017). ">NCT03135301</a>; <a href="./references#CD010287-bbs2-0076" title="WangL , WenX , LvS , ZhaoJ , YangT , YangX . Comparison of endometrial receptivity of clomiphene citrate versus letrozole in women with polycystic ovary syndrome: a randomized controlled study. Gynecological Endocrinology2019;35(10):862-5. ">Wang 2019</a>). The primary reasons for exclusion of the trials were inclusion criteria, interventions, concerns about the validity of the trial data (study retraction/expression of concern) and no randomisation (see <a href="./references#CD010287-sec-0173" title="">Characteristics of excluded studies</a>).  </p> </section> <section id="CD010287-sec-0051"> <h4 class="title">Studies awaiting classification </h4> <p>Fourteen studies are awaiting classification (<a href="./references#CD010287-bbs2-0080" title="AbdellahMS . Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology and Obstetrics2011;113(3):218-21. ">Abdellah 2011</a>; <a href="./references#CD010287-bbs2-0081" title="Abu HashimH , MashalyAM , BadawyA . Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. Archives of Gynecology and Obstetrics2010;282(5):567-71. ">Abu Hashim 2010a</a>; <a href="./references#CD010287-bbs2-0082" title="AygenEM , GuzelZ , OzgunT , AtakulT , SahinY . The use of letrozole for ovulation induction in infertile women with polycystic ovarian syndrome. Erciyes Tip Dergisi2007;29:195-200. ">Aygen 2007</a>; <a href="./references#CD010287-bbs2-0083" title="GhoneimBM , FarahatMA , El-BadryAM , El-GharibMN . Clomiphene-metformin in comparison with letrozole-metformin in overweight infertile women with PCOS. Obstetrics Genecology and Reproductive Sciences2020;4(1):1-8. [DOI: 10.31579/2578-8965/037]">Ghoneim 2020</a>; <a href="./references#CD010287-bbs2-0084" title="JindalPC , SinghR , SinghM . Letrozole versus Clomiphene Citrate for induction of ovulation in PCOS Infertile patients for IUI: a comparative study. Human Reproduction2019;34:Suppl 1. ">Jindal 2019</a>; <a href="./references#CD010287-bbs2-0085" title="KamelMA , AminAF , FarghalyTA , FaragNA . Clomiphene citrate plus N-acetyl cysteine versus letrozole for induction of ovulation in infertile patients with polycystic ovarian disease: a randomized clinical trial. Internatinal Journal of Reproduction, Contraception, Obstetrics and Gynecology2019;8(10):3959-63. ">Kamel 2019</a>; <a href="./references#CD010287-bbs2-0086" title="LorzadehN , KazemiradS , MohammadiZ . Comparison of effects letrozole and clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Iranian Journal of Obstetrics, Gynecology and Infertility2011;14(3):13-19. ">Lorzadeh 2011</a>; <a href="./references#CD010287-bbs2-0087" title="NCT02551367. Letrozole versus clomiphene citrate for ovulation induction in women with polycystic ovary syndrome (PCOS). clinicaltrials.gov/ct2/show/NCT02551367 (first received 16 September 2015). [NCT02551367]">NCT02551367</a>; <a href="./references#CD010287-bbs2-0088" title="NCT02703649. Administration of single high dose letrozole for ovulation induction. clinicaltrials.gov/ct2/show/NCT02703649 (first received 9 March 2016). [NCT02703649]">NCT02703649</a>; <a href="./references#CD010287-bbs2-0089" title="NCT03664050. Laparoscopic ovarian drilling versus letrozole in clomiphene citrate resistant polycystic ovary. clinicaltrials.gov/ct2/show/NCT03664050 (first received 10 September 2018). ">NCT03664050</a>; <a href="./references#CD010287-bbs2-0090" title="RezkM , ShaheenA , El-NasrIS . Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial. Gynecological Endocrinlogy2018;34(4):298-300. ">Rezk 2018</a>; <a href="./references#CD010287-bbs2-0091" title="SafdarianL , DibazarNS , AhmadzadehA , YektaBG . Comparing two ovulation induction methods by brachial artery ultrasonography in infertile women with polycystic ovary syndrome. Tehran University Medical Journal2012;70:242-9. ">Safdarian 2012</a>; <a href="./references#CD010287-bbs2-0092" title="SahaS , ShirazeeHH . Cost effective protocol with letrozole and 3 doses of gonadotropin combination as an alternative to continuous gonadotropin for ovulation induction for IUI in clomiphene resistant PCOS patients - a RCT. Fertility &amp; Sterility2020;114(3):e520. ">Saha 2020</a>; <a href="./references#CD010287-bbs2-0093" title="ShirinG , MehranA , MaryamB , MaryamG , MasoumehM . Comparing the effects of clomiphene-HMG and letrozole-HMG on ovulation Induction in infertile women. Journal of Reproduction and Infertility2009;10(2):109-14. ">Shirin 2009</a>).  </p> </section> <section id="CD010287-sec-0052"> <h4 class="title">Ongoing studies</h4> <p>Seven studies are ongoing (<a href="./references#CD010287-bbs2-0094" title="ChiCTR2100042082. Comparison of the clinical outcomes with different doses of letrozole in PCOS patients undergoing ovulation induction: a prospective, randomized, controlled trial. www.chictr.org.cn/searchprojen.aspx (first received 13 January 2021). ">ChiCTR2100042082</a>; <a href="./references#CD010287-bbs2-0095" title="CTRI/2018/04/013343. A randomized controlled trial comparing the effect of letrozole and clomiphene citrate on endometrial development in infertile women with polycystic ovarian disease [A Randomized Controlled Trial comparing the effect of Letrozole and Clomiphene Citrate on endometrial development in infertile women with Polycystic Ovarian Disease]. www.ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=25010&amp;EncHid=&amp;modid=&amp;compid=%27,%2725010det%27 (first received 20 April 2018). [CTRI/2018/04/013343]">CTRI/2018/04/013343</a>; <a href="./references#CD010287-bbs2-0096" title="CutlerDA , ShawAK , PrideSM , BedaiwyMA , CheungAP . A randomized controlled trial comparing lifestyle intervention to letrozole for ovulation in women with polycystic ovary syndrome: a study protocol. Trials2018;19:632. [https://doi.org/10.1186/s13063-018-3009-5]">Cutler 2018</a>; <a href="./references#CD010287-bbs2-0097" title="HuangS , HuM , NgEH , Stener-VictorinE , ZhengY , WenQ , et al. A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome. Trials2020;4(21):239. [DOI: DOI: 10.1186/s13063-020-4154-1]">Huang 2020</a>; <a href="./references#CD010287-bbs2-0098" title="IRCT2016030926962N2. Comparing the efficacy of long-term and short-term doses of letrozole in ovulation induction among patients with polycystic ovary syndrome. en.irct.ir/trial/22224 (first received 8 May 2016). ">IRCT2016030926962N2</a>; <a href="./references#CD010287-bbs2-0099" title="NCT03009838. Letrozole versus laparoscopic ovarian drilling in polycystic ovary syndrome. clinicaltrials.gov/ct2/show/NCT03009838 (first received 4 January 2017). ">NCT03009838</a>; <a href="./references#CD010287-bbs2-0100" title="PriestL . Letrozole or clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome: a 2x2 factorial design randomised trial (the LOCI trial). ISRCTN registry2019. [ISRCTN11828358]">Priest 2019</a>).   </p> </section> </section> <section id="CD010287-sec-0053"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#CD010287-sec-0172" title="">Characteristics of included studies</a>; <a href="#CD010287-fig-0002">Figure 2</a>; <a href="#CD010287-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD010287-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010287-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD010287-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010287-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD010287-sec-0054"> <h4 class="title">Allocation</h4> <p>Twenty‐four trials were at low risk of selection bias related to random sequence generation. They used computer randomisation, a random‐number table or lottery. The remaining 17 trials did not fully describe their method of randomisation and the contacted authors did not respond, so we rated them at unclear risk of this bias (<a href="#CD010287-fig-0002">Figure 2</a>). </p> <p>Ten trials were at low risk of selection bias related to allocation concealment. They used sequentially‐numbered, sealed (opaque) envelopes and the list was kept by a third party during the procedure, or the randomisation schedule was produced by an interactive voice response system vendor. The other 31 trials did not describe allocation concealment sufficiently and the authors did not respond to our emails, so we rated them at unclear risk of bias (<a href="#CD010287-fig-0002">Figure 2</a>). </p> </section> <section id="CD010287-sec-0055"> <h4 class="title">Blinding</h4> <p>Eight out of 41 trials described the blinding of participants and personnel, and were thus rated at low risk of performance bias. Twenty‐six trials did not mention blinding of participants of personnel and the authors did not respond to our emails, so we rated them at unclear risk of bias. Seven trials stated that there was no blinding of participants or personnel or both, and were at high risk of bias (<a href="#CD010287-fig-0002">Figure 2</a>). </p> <p>Eleven of 41 trials reported that the outcome assessors were blinded and were therefore at low risk of bias. Twenty‐five trials did not mention blinding of outcome assessors and the authors did not respond to our email contact, so were rated at unclear risk of bias. Five trials were at high risk of detection bias, because they reported that the outcome assessors were not blinded (<a href="#CD010287-fig-0002">Figure 2</a>). </p> </section> <section id="CD010287-sec-0056"> <h4 class="title">Incomplete outcome data</h4> <p>Thirty‐six of 41 trials included all or nearly all women they had randomised (more than 90%) and were therefore at low risk of attrition bias. Three trials were at unclear risk of attrition bias. One trial had peculiar group numbers and none of the other biases were addressed, so we tried without success to contact the authors (<a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>). Another two trials did not report how many women were originally randomised (<a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>; <a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>). Two more trials were at high risk of attrition bias: one trial because 13 of 80 women were not analysed. Four women were excluded after randomisation due to an ovarian cyst on sonography on day 3. Nine more women were lost to follow‐up without any reasons given (<a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>). The second trial excluded 28 of 268 women from analysis; 13 were lost to follow‐up, three were excluded, and 12 had complications (<a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="#CD010287-fig-0002">Figure 2</a>). </p> </section> <section id="CD010287-sec-0057"> <h4 class="title">Selective reporting</h4> <p>Thirty of the 41 included trials reported the outcomes they had stated in the Methods section, and we therefore judged them to be at low risk of bias. In 11 of the 41 trials only a few outcomes were presented and the contacted authors did not respond, so we rated them at unclear risk of reporting bias (<a href="#CD010287-fig-0002">Figure 2</a>). </p> </section> <section id="CD010287-sec-0058"> <h4 class="title">Other potential sources of bias</h4> <p>In one trial there were substantial baseline differences in age and duration of infertility between the two groups and we deemed the risk of bias to be high (<a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>). In a second trial, the methods were not well described and the clinical trial registration number led to a different trial (<a href="./references#CD010287-bbs2-0040" title="ZareiA , ShabahramiTB , DadrasN . Effects of letrozole in prevention of premature luteinizing hormone (LH) surge in infertile women with clomiphene citrate resistant polycystic ovary syndrome (PCOS) undergoing intrauterine insemination. Galen Medical Journal2015;4(3):104-11. ">Zarei 2015</a>). In a third trial, the methods were also not well described in general and the sample size was very small (<a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>). In a fourth trial the power calculation implied a very strong effect in favour of letrozole compared to CC (<a href="./references#CD010287-bbs2-0003" title="AshfaqA , TahseenH , NoreenZ , AlamN . Clomiphene citrate vs letrozole in PCO's patient's for ovulation induction. Pakistan Journal of Medical and Health Sciences2018;12(2):781-3. ">Ashfaq 2018</a>). We judged two trials to be at unclear risk of other bias (<a href="./references#CD010287-bbs2-0019" title="HendawySF , SamahaHE , ElkholyMF . Letrozole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clinical Medicine Insights: Reproductive Health2011;5:11-16. ">Hendawy 2011</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>). We found no potential sources of within‐study bias in the other trials (<a href="#CD010287-fig-0002">Figure 2</a>). </p> </section> </section> <section id="CD010287-sec-0059"> <h3 class="title" id="CD010287-sec-0059">Effects of interventions</h3> <p>See: <a href="./full#CD010287-tbl-0001"><b>Summary of findings 1</b> Letrozole with or without adjuncts compared to SERMs with or without adjuncts followed by timed intercourse for infertile women with polycystic ovary syndrome</a>; <a href="./full#CD010287-tbl-0002"><b>Summary of findings 2</b> Letrozole compared to laparoscopic ovarian drilling for infertile women with polycystic ovary syndrome</a> </p> <section id="CD010287-sec-0060"> <h4 class="title">1. Letrozole compared to placebo</h4> <section id="CD010287-sec-0061"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0062"> <h6 class="title">1.1 Live birth rate</h6> <p>Two trials including 167 participants compared an AI (letrozole) with placebo (<a href="./references#CD010287-bbs2-0021" title="KamathMS , AleyammaTK , ChandyA , GeorgeK . Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility2010;94(7):2857-9. ">Kamath 2010</a>; <a href="./references#CD010287-bbs2-0040" title="ZareiA , ShabahramiTB , DadrasN . Effects of letrozole in prevention of premature luteinizing hormone (LH) surge in infertile women with clomiphene citrate resistant polycystic ovary syndrome (PCOS) undergoing intrauterine insemination. Galen Medical Journal2015;4(3):104-11. ">Zarei 2015</a>). Only one trial reported live birth rate, and there was insufficient evidence to suggest a difference in live birth rate (odds ratio (OR) 3.17, 95% confidence interval (CI) 0.12 to 83.17; 1 trial, 36 participants; <a href="./references#CD010287-fig-0008" title="">Analysis 1.1</a>). </p> </section> <section id="CD010287-sec-0063"> <h6 class="title">1.2 OHSS rate</h6> <p>A risk difference (RD) analysis for OHSS rate showed insufficient evidence of a difference in frequency of this adverse event (RD 0.00, 95% CI −0.05 to 0.05; I<sup>2</sup> = 0%; 2 trials, 167 participants; <a href="./references#CD010287-fig-0009" title="">Analysis 1.2</a>). </p> </section> </section> <section id="CD010287-sec-0064"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0065"> <h6 class="title">1.3 Clinical pregnancy rate</h6> <p>The clinical pregnancy rate was higher using letrozole compared to placebo (OR 2.88, 95% CI 1.08 to 7.66; I<sup>2</sup> = 0%; 2 trials, 167 participants; <a href="./references#CD010287-fig-0010" title="">Analysis 1.3</a>). </p> </section> <section id="CD010287-sec-0066"> <h6 class="title">1.4 Miscarriage rate per woman and per pregnancy</h6> <p>Due to a wide CI in our analysis for miscarriage rate, compared to placebo, we are uncertain if letrozole decreases miscarriage rate per woman (OR 1.60, 95% CI 0.26 to 9.89; 2 trials, 167 participants; <a href="./references#CD010287-fig-0011" title="">Analysis 1.4</a>) or per pregnancy (OR 0.55, 95% CI 0.07 to 4.56; 1 trial, 20 participants; <a href="./references#CD010287-fig-0012" title="">Analysis 1.5</a>).  </p> </section> <section id="CD010287-sec-0067"> <h6 class="title">1.5 Multiple pregnancy rate</h6> <p>Multiple pregnancy rate was not estimable because there were no cases reported. Sensitivity and subgroup analyses were not possible because there were too few trials. </p> </section> </section> </section> <section id="CD010287-sec-0068"> <h4 class="title">2. Letrozole with or without adjuncts compared to SERMs with or without adjuncts followed by timed intercourse </h4> <p>23 trials including 3321 women compared letrozole to SERMs, with or without adjuncts (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0012" title="EL-GharibMN , MahfouzAE , FarahatMA . Comparison of letrozole versus tamoxifen effects in clomiphene citrate resistant women with polycystic ovarian syndrome. Journal of Reproduction and Infertility2015;16(1):30-5. ">El‐Gharib 2015</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0026" title="MoussaAA , TorkyH , DiefO , ElwahedAA , SennaHA . The effect of clomiphene citrate versus tamoxifen versus letrozole on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Medica International2016;3(2):88-92. ">Moussa 2016</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>; <a href="./references#CD010287-bbs2-0036" title="Sheikh-El-Arab ElsedeekM , ElmaghrabyHA . Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal2011;16(2):125-30. ">Sh‐El‐Arab Elsedeek 2011</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>). </p> <p> <ul id="CD010287-list-0015"> <li> <p>Letrozole (2.5 mg to 7.5 mg/day) versus SERMs such as CC (50 mg to 150 mg/day), either alone or in combination with metformin (1000 mg to 1500 mg daily); 75 IU hMG to 150 IU hMG in one or both arms; estradiol valerate 4 mg/day. </p> </li> </ul> </p> <section id="CD010287-sec-0069"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0070"> <h6 class="title">2.1 Live birth rate</h6> <p>Eleven trials including 2060 women compared letrozole to SERMs, with or without adjuncts in one or both arms, and reported live birth rate (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>). Letrozole resulted in an increased live birth rate compared to SERMs for ovulation induction (OR 1.72, 95% CI 1.40 to 2.11; I<sup>2</sup> = 0%; number needed to treat for an additional beneficial outcome (NNTB) = 10; 11 trials, 2060 participants; high‐certainty evidence; <a href="#CD010287-fig-0004">Figure 4</a>; <a href="./references#CD010287-fig-0014" title="">Analysis 2.1</a>). This suggests that in women with a 20% chance of live birth using SERMs with or without adjuncts, the live birth rate in women using letrozole with or without adjuncts would be 27% to 35%.  </p> <div class="figure" id="CD010287-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators (SERMs), outcome: 2.1 Live birth rate." data-id="CD010287-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators (SERMs), outcome: 2.1 Live birth rate. </p> </div> </div> </div> <p>Eight of the 11 trials compared letrozole alone with CC alone (OR 1.79, 95% CI 1.42 to 2.25; I<sup>2</sup> = 0%; 1646 participants) </p> <p>Subgroup analysis showed insufficient evidence to suggest a difference by mean BMI above or below 25 (P = 0.87). Another subgroup analysis showed insufficient evidence to suggest a difference in women that were CC‐resistant versus women who had no previous treatment for ovulation induction (P = 0.80) (analysis not shown).  </p> <p>Sensitivity analysis excluding one trial with high risk of detection bias showed no substantive influence on the treatment effect (<a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>). A sensitivity analysis comparing trials with unclear and low risk for allocation bias also showed insufficient evidence for a difference in treatment effect between the two subgroups (P = 0.36). In our other sensitivity analyses, findings for live birth were not influenced by the use of a random‐effects model, alternative imputation strategies, or RR rather than OR. A funnel plot for live birth rate was symmetrical, indicating that our findings might not be influenced by publication bias (<a href="#CD010287-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD010287-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 AIs compared to SERMs with or without adjuncts, followed by timed intercourse, outcome: 2.1 Live birth rate." data-id="CD010287-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 AIs compared to SERMs with or without adjuncts, followed by timed intercourse, outcome: 2.1 Live birth rate. </p> </div> </div> </div> </section> <section id="CD010287-sec-0071"> <h6 class="title">2.2 OHSS rate</h6> <p>Ten trials including 1848 women compared letrozole to SERMs, with or without adjuncts in one or both arms, and reported the occurrence of OHSS (<a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>). Our RD analysis showed that there is high‐certainty evidence of a similar frequency of this adverse event in both groups (RD −0.00, 95% CI −0.01 to 0.01; I<sup>2</sup> = 0%; 10 trials, 1848 participants; high‐certainty evidence; <a href="#CD010287-fig-0006">Figure 6</a>; <a href="./references#CD010287-fig-0020" title="">Analysis 2.7</a>). This suggests that the risk of OHSS was 0.5% in both groups. No OHSS occurred in women that were treated with letrozole alone. A subgroup analysis showed insufficient evidence to suggest a difference by BMI mean (P = 0.79) (analysis not shown). No differences in results were observed in our prespecified sensitivity analyses. A funnel plot for OHSS was insufficient for detection of a potential publication bias because there were no events in most of the trials (analysis not shown). </p> <div class="figure" id="CD010287-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators SERMs, outcome: 2.6 Ovarian hyperstimulation syndrome rate." data-id="CD010287-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators SERMs, outcome: 2.6 Ovarian hyperstimulation syndrome rate. </p> </div> </div> </div> </section> </section> <section id="CD010287-sec-0072"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0073"> <h6 class="title">2.3 Clinical pregnancy rate</h6> <p>Clinical pregnancy rate was reported in 23 trials, including 3321 women (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0012" title="EL-GharibMN , MahfouzAE , FarahatMA . Comparison of letrozole versus tamoxifen effects in clomiphene citrate resistant women with polycystic ovarian syndrome. Journal of Reproduction and Infertility2015;16(1):30-5. ">El‐Gharib 2015</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0026" title="MoussaAA , TorkyH , DiefO , ElwahedAA , SennaHA . The effect of clomiphene citrate versus tamoxifen versus letrozole on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Medica International2016;3(2):88-92. ">Moussa 2016</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>; <a href="./references#CD010287-bbs2-0036" title="Sheikh-El-Arab ElsedeekM , ElmaghrabyHA . Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal2011;16(2):125-30. ">Sh‐El‐Arab Elsedeek 2011</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>). Use of letrozole resulted in a higher clinical pregnancy rate compared to SERMs, with or without adjuncts in one or both arms (OR 1.69, 95% CI 1.45 to 1.98; I<sup>2</sup> = 0%; NNTB = 10; 23 trials, 3321 participants; high‐certainty evidence; <a href="./references#CD010287-fig-0022" title="">Analysis 2.9</a>). This suggests that in women with a 24% chance of clinical pregnancy using SERMs with or without adjuncts, the clinical pregnancy rate in women using letrozole with or without adjuncts would be 32% to 39%. No differences in results were observed in our prespecified sensitivity analyses. A funnel plot for clinical pregnancy rate was symmetrical, indicating that our findings might not be influenced by publication bias (analysis not shown). </p> </section> <section id="CD010287-sec-0074"> <h6 class="title">2.4 Miscarriage rate per woman and per pregnancy</h6> <p>Miscarriage rate was reported in 15 trials, including 2422 women (<a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>). The analysis of miscarriage rate per woman showed little evidence for a difference in favour of SERMs with or without adjuncts in one or both arms (OR 1.37, 95% CI 1.01 to 1.87; I<sup>2</sup> = 0%; 15 trials, 2422 participants; high‐certainty evidence; <a href="./references#CD010287-fig-0024" title="">Analysis 2.11</a>). However, the results of the analysis of miscarriage rate per pregnancy showed little or no difference between the groups (OR 0.94, 95% CI 0.66 to 1.32; I<sup>2</sup> = 0%; 15 trials, 736 participants; high‐certainty evidence; <a href="./references#CD010287-fig-0025" title="">Analysis 2.12</a>). This suggests that in women with a 25% risk of miscarriage per pregnancy using SERMs with or without adjuncts, the miscarriage rate in women using letrozole with or without adjuncts would be 18% to 30%.  </p> </section> <section id="CD010287-sec-0075"> <h6 class="title">2.5 Multiple pregnancy rate</h6> <p>Multiple pregnancy rate was reported in 14 trials, including 2247 women (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0019" title="HendawySF , SamahaHE , ElkholyMF . Letrozole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clinical Medicine Insights: Reproductive Health2011;5:11-16. ">Hendawy 2011</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>; <a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>). The analysis of multiple pregnancy rate per woman showed high‐certainty evidence of no difference in multiple pregnancy rate for letrozole compared to SERMs (OR 0.74, 95% CI 0.42 to 1.32; I<sup>2</sup> = 0%; 14 trials, 2247 participants; high‐certainty evidence; <a href="#CD010287-fig-0007">Figure 7</a>; <a href="./references#CD010287-fig-0026" title="">Analysis 2.13</a>). This suggests that in women with a 2.2% chance of multiple pregnancy using SERMs with or without adjuncts, the multiple pregnancy rate in women using letrozole with or without adjuncts would be 1.6% to 2.8%.  </p> <div class="figure" id="CD010287-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators SERMs, outcome: 2.5 Multiple pregnancy rate." data-id="CD010287-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators SERMs, outcome: 2.5 Multiple pregnancy rate. </p> </div> </div> </div> </section> </section> <section id="CD010287-sec-0076"> <h5 class="title">Publication bias </h5> <p>We produced a funnel plot for both primary outcomes and for the outcome of clinical pregnancy rate. A funnel plot for live birth rate was symmetrical, indicating that our findings might not be influenced by publication bias (<a href="#CD010287-fig-0005">Figure 5</a>). A funnel plot for OHSS was insufficient for detection of a potential publication bias because there were no events in most of the trials (analysis not shown). The funnel plot for the secondary outcome clinical pregnancy rate showed some asymmetries, with a gap on the left side. This indicates that there were possibly some trials with effects in favour of SERMs which were not reported, and therefore the results of our meta‐analysis might have overestimated the effect of letrozole on pregnancy rate. </p> </section> </section> <section id="CD010287-sec-0077"> <h4 class="title">3. Letrozole compared to SERMs with or without adjuncts followed by intrauterine insemination</h4> <p>Three trials including 1597 women compared the use of letrozole with or without adjuncts to SERMs followed by intrauterine insemination (<a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). </p> <p> <ul id="CD010287-list-0016"> <li> <p>Letrozole (2.5 mg to 5 mg daily, cycle days 3 to 7 or 2 to 6) versus SERMs such as CC (50 mg to 150 mg daily, cycle days 3 to 7 or 2 to 6) with or without adjuncts or recombinant follicle‐stimulating hormone (rFSH) only (rFSH 75 IU to 100 IU from day 2 until the day of hCG administration). </p> </li> </ul> </p> <section id="CD010287-sec-0078"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0079"> <h6 class="title">3.1 Live birth rate</h6> <p>No trials comparing letrozole to SERMs reported live birth rate.</p> </section> <section id="CD010287-sec-0080"> <h6 class="title">3.2 OHSS rate</h6> <p>Two trials reported OHSS rate comparing use of letrozole to SERMs (<a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). Our RD analysis showed insufficient evidence of a difference in frequency of this adverse event between the two treatment groups (RD −0.00, 95% CI −0.01 to 0.00; I<sup>2</sup> = 0%; 2 trials, 1494 participants; <a href="./references#CD010287-fig-0027" title="">Analysis 3.1</a>). Sensitivity and subgroup analyses were not possible because there were too few trials. </p> </section> </section> <section id="CD010287-sec-0081"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0082"> <h6 class="title">3.3 Clinical pregnancy rate</h6> <p>Clinical pregnancy rate was reported in three trials comparing letrozole to SERMs (<a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). The analysis showed evidence in favour of letrozole compared to SERMs for ovulation induction followed by intrauterine insemination (OR 1.71, 95% CI 1.30 to 2.25; I<sup>2</sup> = 0%; 3 trials, 1597 participants; <a href="./references#CD010287-fig-0028" title="">Analysis 3.2</a>). </p> </section> <section id="CD010287-sec-0083"> <h6 class="title">3.4 Miscarriage rate per woman and per pregnancy</h6> <p>Miscarriage rate was reported in two trials comparing letrozole to SERMs (<a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>). There was insufficient evidence of a difference between the two groups for miscarriage rate per woman (OR 1.22, 95% CI 0.62 to 2.40; I<sup>2</sup> = 30%; 2 trials, 1490 participants; <a href="./references#CD010287-fig-0029" title="">Analysis 3.3</a>) or per pregnancy (OR 0.76, 95% CI 0.37 to 1.57; I<sup>2</sup> = 0%; 2 trials, 260 participants; <a href="./references#CD010287-fig-0030" title="">Analysis 3.4</a>). </p> </section> <section id="CD010287-sec-0084"> <h6 class="title">3.5 Multiple pregnancy rate</h6> <p>Multiple pregnancy rate was reported in three trials comparing letrozole to SERMs, with or without adjuncts (<a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). There was insufficient evidence of a difference between the two groups (OR 1.03, 95% CI 0.49 to 2.13; I<sup>2</sup> = 0%; 3 trials, 1597 participants; <a href="./references#CD010287-fig-0031" title="">Analysis 3.5</a>). </p> </section> </section> </section> <section id="CD010287-sec-0085"> <h4 class="title">4. Letrozole compared to LOD</h4> <p>Three trials including 367 women compared letrozole with or without metformin to LOD (<a href="./references#CD010287-bbs2-0011" title="ElgaforIA . Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2013;288(1):119-23. [DOI: 10.1007/s00404-013-2714-2]">Elgafor 2013</a>; <a href="./references#CD010287-bbs2-0020" title="IbrahimMH , TawficM , HassanMM , SedkyOH . Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate. Middle East Fertility Society Journal2017;22(4):251-4. ">Ibrahim 2017</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>). </p> <p> <ul id="CD010287-list-0017"> <li> <p>Letrozole (2.5 mg to 5 mg daily, cycle days 3 to 7) with or without metformin (850 mg to 1700 mg daily for 6 to 8 weeks) versus laparoscopic ovarian drilling. </p> </li> </ul> </p> <section id="CD010287-sec-0086"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0087"> <h6 class="title">4.1 Live birth rate</h6> <p>Live birth rate was reported in one trial including 141 women, comparing letrozole to LOD (<a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>). There was very low‐certainty evidence of a higher live birth rate in favour of letrozole compared to LOD (OR 2.07, 95% CI 0.99 to 4.32; 1 trial, 141 participants; <a href="./references#CD010287-fig-0032" title="">Analysis 4.1</a>). This suggests that in women with a 22% chance of live birth using LOD with or without adjuncts, the live birth rate in women using letrozole with or without adjuncts would be 24% to 47%. Subgroup and sensitivity analyses were not possible because there was only one trial. </p> </section> <section id="CD010287-sec-0088"> <h6 class="title">4.2 OHSS rate</h6> <p>No trials comparing letrozole to LOD reported OHSS rate.</p> </section> </section> <section id="CD010287-sec-0089"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0090"> <h6 class="title">4.3 Clinical pregnancy rate</h6> <p>Clinical pregnancy rate was reported in three trials including 367 women, comparing letrozole with or without metformin to LOD (<a href="./references#CD010287-bbs2-0011" title="ElgaforIA . Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2013;288(1):119-23. [DOI: 10.1007/s00404-013-2714-2]">Elgafor 2013</a>; <a href="./references#CD010287-bbs2-0020" title="IbrahimMH , TawficM , HassanMM , SedkyOH . Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate. Middle East Fertility Society Journal2017;22(4):251-4. ">Ibrahim 2017</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>). There was low‐certainty evidence of no difference between the two groups (OR 1.47, 95% CI 0.95 to 2.28; I<sup>2</sup> = 0%; 3 trials, 367 participants; <a href="./references#CD010287-fig-0033" title="">Analysis 4.2</a>). This suggests that in women with a 29% chance of clinical pregnancy using LOD with or without adjuncts, the clinical pregnancy rate in women using letrozole with or without adjuncts would be 28% to 45%. </p> </section> <section id="CD010287-sec-0091"> <h6 class="title">4.4 Miscarriage rate per woman and per pregnancy</h6> <p>Miscarriage rate was reported in three trials including 367 women, comparing letrozole with or without metformin to LOD (<a href="./references#CD010287-bbs2-0011" title="ElgaforIA . Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2013;288(1):119-23. [DOI: 10.1007/s00404-013-2714-2]">Elgafor 2013</a>; <a href="./references#CD010287-bbs2-0020" title="IbrahimMH , TawficM , HassanMM , SedkyOH . Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate. Middle East Fertility Society Journal2017;22(4):251-4. ">Ibrahim 2017</a>; <a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>). There was low‐certainty evidence of no difference between the two groups for miscarriage rate per woman (OR 0.87, 95% CI 0.31 to 2.44; I<sup>2</sup> = 0%; 3 trials, 367 participants; <a href="./references#CD010287-fig-0034" title="">Analysis 4.3</a>) and per pregnancy (OR 0.65, 95% CI 0.22 to 1.38; I<sup>2</sup> = 0%; 3 trials, 122 participants; <a href="./references#CD010287-fig-0035" title="">Analysis 4.4</a>). This suggests that in women with a 16% risk of miscarriage per pregnancy using LOD with or without adjuncts, the risk of miscarriage in women using letrozole with or without adjuncts would be 4% to 21%. </p> </section> <section id="CD010287-sec-0092"> <h6 class="title">4.5 Multiple pregnancy rate</h6> <p>Multiple pregnancy rate was reported in one trial including 141 women, comparing letrozole to LOD (<a href="./references#CD010287-bbs2-0024" title="LiuW , DongS , LiY , ShiL , ZhouW , LiuY , et al. Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome. Experimental and Therapeutic Medicine2015;10(4):1297-1302. ">Liu 2015</a>). There was low‐certainty evidence of no difference between the two groups for multiple pregnancy rate per woman (OR 3.00, 95% CI 0.12 to 74.90; I<sup>2</sup> = 0%; 1 trial, 141 participants; <a href="./references#CD010287-fig-0036" title="">Analysis 4.5</a>). The risk of multiple pregnancy was below 1% in both treatment groups. </p> </section> </section> </section> <section id="CD010287-sec-0093"> <h4 class="title">5. Letrozole compared to FSH</h4> <p>Two trials including 236 women compared use of letrozole to FSH (<a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>). </p> <p> <ul id="CD010287-list-0018"> <li> <p>Letrozole 2.5 mg twice daily for 5 days versus urinary FSH (uFSH) 75 IU a day for 7 days (<a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>) or human menopausal gonadotropin (hMG) 75 IU a day for 5 days (<a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>), both groups starting on the third day of menstruation. </p> </li> </ul> </p> <section id="CD010287-sec-0094"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0095"> <h6 class="title">5.1 Live birth rate</h6> <p>Live birth rate was reported in one trial comparing letrozole to hMG (<a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>). There was insufficient evidence of a difference between the two groups (OR 1.00, 95% CI 0.34 to 2.93; 1 trial, 96 participants; <a href="./references#CD010287-fig-0037" title="">Analysis 5.1</a>). </p> </section> <section id="CD010287-sec-0096"> <h6 class="title">5.2 OHSS rate</h6> <p>OHSS was reported in two trials comparing letrozole to gonadotropins (<a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>). A RD analysis showed insufficient evidence of a difference between the two treatment groups (RD ‐0.03, 95% CI −0.08 to 0.01; 2 trials, 236 participants; <a href="./references#CD010287-fig-0038" title="">Analysis 5.2</a>). </p> </section> </section> <section id="CD010287-sec-0097"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0098"> <h6 class="title">5.3 Clinical pregnancy rate</h6> <p>Clinical pregnancy rate was reported in two trials comparing letrozole to gonadotropins (<a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>). There was insufficient evidence of a difference between the two groups (OR 0.81, 95% CI 0.46 to 1.43; 2 trials, 236 participants; <a href="./references#CD010287-fig-0039" title="">Analysis 5.3</a>). </p> </section> <section id="CD010287-sec-0099"> <h6 class="title">5.4 Miscarriage rate per woman and per pregnancy</h6> <p>Miscarriage rate was reported in two trials comparing letrozole to gonadotropins (<a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>). There was insufficient evidence of a difference between the two groups for miscarriage rate per woman (OR 0.61, 95% CI 0.19 to 1.92; 2 trials, 236 participants; <a href="./references#CD010287-fig-0040" title="">Analysis 5.4</a>) or per pregnancy (OR 0.74, 95% CI 0.11 to 4.90; 1 trial, 140 participants; <a href="./references#CD010287-fig-0041" title="">Analysis 5.5</a>). </p> </section> <section id="CD010287-sec-0100"> <h6 class="title">5.5 Multiple pregnancy rate</h6> <p>Multiple pregnancy rate was reported in two trials comparing letrozole to FSH (<a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>). There was insufficient evidence to suggest a difference between the two treatment groups (OR 0.22, 95% CI 0.04 to 1.32; 2 trials, 236 participants; <a href="./references#CD010287-fig-0042" title="">Analysis 5.6</a>). </p> </section> </section> </section> <section id="CD010287-sec-0101"> <h4 class="title">6. Letrozole compared to anastrozole</h4> <p>One trial including 40 women compared letrozole to the AI, anastrozole (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>). </p> <p> <ul id="CD010287-list-0019"> <li> <p>Letrozole 2.5 mg/day versus anastrozole 1 mg/day for 5 days, both starting on cycle day 3. </p> </li> </ul> </p> <section id="CD010287-sec-0102"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0103"> <h6 class="title">6.1 Live birth rate</h6> <p>No trials comparing letrozole to anastrozole reported live birth rate.</p> </section> <section id="CD010287-sec-0104"> <h6 class="title">6.2 OHSS rate</h6> <p>No trials comparing letrozole to anastrozole reported OHSS rate.</p> </section> </section> <section id="CD010287-sec-0105"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0106"> <h6 class="title">6.3 Clinical pregnancy rate</h6> <p>Clinical pregnancy rate was reported in one trial comparing letrozole to anastrozole (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>). There was insufficient evidence of a difference between the two groups (OR 1.88, 95% CI 0.40 to 8.88; 40 participants; 1 trial; <a href="./references#CD010287-fig-0043" title="">Analysis 6.1</a>). </p> </section> <section id="CD010287-sec-0107"> <h6 class="title">6.4 Miscarriage rate per woman and per pregnancy</h6> <p>No trials comparing letrozole to anastozole reported miscarriage rate per woman or per pregnancy. </p> </section> <section id="CD010287-sec-0108"> <h6 class="title">6.5 Multiple pregnancy rate</h6> <p>Multiple pregnancy rate was reported in one trial comparing letrozole to anastrozole (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>). This trial did not report any cases of multiple pregnancies and an OR was therefore not estimable (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>; <a href="./references#CD010287-fig-0044" title="">Analysis 6.2</a>). </p> </section> </section> </section> <section id="CD010287-sec-0109"> <h4 class="title">7. Letrozole compared to berberine followed by timed intercourse</h4> <p>One trial including 644 women compared letrozole to berberine (<a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>). </p> <p> <ul id="CD010287-list-0020"> <li> <p>Letrozole 2.5 mg/day starting on cycle day 3 versus berberine 1.5 g for 6 months</p> </li> </ul> </p> <section id="CD010287-sec-0110"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0111"> <h6 class="title">7.1 Live birth rate</h6> <p>Live birth rate was reported in one trial comparing letrozole to berberine (<a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>). Letrozole resulted in an increased live birth rate compared to berberine (OR 1.94, 95% CI 1.33 to 2.84; 1 trial, 644 participants; <a href="./references#CD010287-fig-0045" title="">Analysis 7.1</a>). </p> </section> <section id="CD010287-sec-0112"> <h6 class="title">7.2 OHSS rate</h6> <p>No trials comparing letrozole to berberine reported OHSS rate.</p> </section> </section> <section id="CD010287-sec-0113"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0114"> <h6 class="title">7.3 Clinical pregnancy rate</h6> <p>Clinical pregnancy rate was reported in one trial comparing letrozole to berberine (<a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>). Letrozole resulted in an increased pregnancy rate compared to berberine (OR 2.15, 95% CI 1.48 to 3.13; 1 trial, 644 participants; <a href="./references#CD010287-fig-0046" title="">Analysis 7.2</a>). </p> </section> <section id="CD010287-sec-0115"> <h6 class="title">7.4 Miscarriage rate per woman and per pregnancy</h6> <p>Miscarriage rate was reported in one trial comparing letrozole to berberine (<a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>). There was insufficient evidence of a difference between the two groups for miscarriage rate per women randomised (OR 1.60, 95% CI 0.26 to 9.89; 1 trial, 644 participants; <a href="./references#CD010287-fig-0047" title="">Analysis 7.3</a>) and for miscarriage rate per pregnancy (OR 4.53, 95% CI 0.24 to 84.46; 1 trial, 644 participants; <a href="./references#CD010287-fig-0048" title="">Analysis 7.4</a>). </p> </section> <section id="CD010287-sec-0116"> <h6 class="title">7.5 Multiple pregnancy rate</h6> <p>Multiple pregnancy rate was reported in one trial comparing letrozole to anastrozole (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>). This trial did not report any cases of multiple pregnancies and an OR was therefore not estimable (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>; <a href="./references#CD010287-fig-0044" title="">Analysis 6.2</a>). </p> </section> </section> </section> <section id="CD010287-sec-0117"> <h4 class="title">8. Different administration protocols of letrozole</h4> <section id="CD010287-sec-0118"> <h5 class="title">Letrozole day 3‐7 administration versus day 5‐9 administration</h5> <p>One trial including 70 women compared starting letrozole on day 3 with day 5 administration protocol (<a href="./references#CD010287-bbs2-0017" title="GhomianN , KhosraviA , MousavifarN . A randomized clinical trial on comparing the cycle characteristics of two different initiation days of letrozole treatment in clomiphene citrate resistant PCOS patients in IUI cycles. International Journal of Fertility and Sterility2015;9(1):17-26. ">Ghomian 2015</a>). </p> </section> <section id="CD010287-sec-0119"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0120"> <h6 class="title">8.1 Live birth rate</h6> <p>This trial did not report live birth rate.</p> </section> <section id="CD010287-sec-0121"> <h6 class="title">8.2 OHSS rate</h6> <p>This trial did not report OHSS rate.</p> </section> </section> <section id="CD010287-sec-0122"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0123"> <h6 class="title">8.3 Clinical pregnancy rate</h6> <p>The analysis showed insufficient evidence of a difference between the two groups in clinical pregnancy rate (OR 1.38, 95% CI 0.28 to 6.66; 1 trial, 70 participants; <a href="./references#CD010287-fig-0050" title="">Analysis 8.1</a>). </p> </section> <section id="CD010287-sec-0124"> <h6 class="title">8.4 Miscarriage rate</h6> <p>This trial did not report miscarriage rate.</p> </section> <section id="CD010287-sec-0125"> <h6 class="title">8.5 Multiple pregnancy rate</h6> <p>This trial did not report multiple pregnancy rate.</p> </section> </section> </section> <section id="CD010287-sec-0126"> <h4 class="title">9. Dosage studies of letrozole</h4> <p>One trial compared a 5 mg/day administration of letrozole to a 7.5 mg/day administration protocol (<a href="./references#CD010287-bbs2-0029" title="RamezanzadehF , NasiriR , YazdiMS , BaghreiM . A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Archives of Gynecology and Obstetrics2011;284(4):1029-34. ">Ramezanzadeh 2011</a>). </p> <section id="CD010287-sec-0127"> <h5 class="title">Primary outcomes</h5> <section id="CD010287-sec-0128"> <h6 class="title">9.1 Live birth rate</h6> <p>This trial did not report live birth rate.</p> </section> <section id="CD010287-sec-0129"> <h6 class="title">9.2 OHSS rate</h6> <p>A RD analysis on OHSS rate showed insufficient evidence to suggest a difference in occurrence of OHSS between the two treatment groups (RD 0.00, 95% CI −0.05 to 0.05; 1 trial, 80 participants; <a href="./references#CD010287-fig-0051" title="">Analysis 9.1</a>). </p> </section> </section> <section id="CD010287-sec-0130"> <h5 class="title">Secondary outcomes</h5> <section id="CD010287-sec-0131"> <h6 class="title">9.3 Clinical pregnancy rate</h6> <p>The results show insufficient evidence of a difference between the groups in clinical pregnancy rate (OR 1.00, 95% CI 0.32 to 3.17; 1 trial, 80 participants; <a href="./references#CD010287-fig-0052" title="">Analysis 9.2</a>). </p> </section> <section id="CD010287-sec-0132"> <h6 class="title">9.4 Miscarriage rate per woman and per pregnancy</h6> <p>The results show insufficient evidence of a difference between the groups in miscarriage rate per woman (OR 0.33, 95% CI 0.01 to 8.22; 1 trial, 80 participants; <a href="./references#CD010287-fig-0053" title="">Analysis 9.3</a>), or miscarriage rate per pregnancy (OR 0.29, 95% CI 0.01 to 8.39; 1 trial, 80 participants; <a href="./references#CD010287-fig-0054" title="">Analysis 9.4</a>). </p> <p><b>9.5 Multiple pregnancy rate</b> </p> <p>The results show insufficient evidence of a difference between the groups in multiple pregnancy rate (OR 1.00, 95% CI 0.06 to 16.56; 1 trial, 80 participants; <a href="./references#CD010287-fig-0055" title="">Analysis 9.5</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010287-sec-0133" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010287-sec-0133"></div> <section id="CD010287-sec-0134"> <h3 class="title" id="CD010287-sec-0134">Summary of main results</h3> <section id="CD010287-sec-0135"> <h4 class="title">Letrozole compared to placebo</h4> <p>Two trials compared letrozole to placebo. There is a lack of evidence with only two small studies with small numbers of participants. </p> </section> <section id="CD010287-sec-0136"> <h4 class="title">Letrozole compared to SERMs with or without adjuncts followed by timed intercourse</h4> <p>The results of our analysis of 23 trials comparing letrozole to SERMs followed by timed intercourse suggest that letrozole improves the live birth rate and pregnancy rate compared to SERMs (<a href="./full#CD010287-tbl-0001">summary of findings Table 1</a>). </p> <p>A funnel plot for live birth rate was symmetrical, indicating that our findings might not be influenced by publication bias (<a href="#CD010287-fig-0005">Figure 5</a>). </p> <p>Letrozole resulted in 10% more pregnancies, consequently the miscarriage rate expressed per woman was also higher. However, the miscarriage rate expressed per pregnancy was comparable between letrozole and SERMs. A RD analysis suggested that letrozole and CC are equally safe in terms of ovarian hyperstimulation and miscarriage rates (<a href="./full#CD010287-tbl-0001">summary of findings Table 1</a>). </p> <p>The funnel plot for clinical pregnancy rate was symmetrical, suggesting that our findings might not be influenced by publication bias. A funnel plot investigating the impact of possible allocation bias on clinical pregnancy rate showed some asymmetry, suggesting that the results might be influenced by allocation bias in favour of letrozole. </p> <p>All analyses had absent or low levels of statistical heterogeneity (I<sup>2</sup> &lt; 25%). </p> <p>Six of our 23 trials in this analysis included women resistant to CC (<a href="./references#CD010287-bbs2-0006" title="BegumMR , FerdousJ , BegumA , QuadirE . Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility2009;92(3):853-7. ">Begum 2009</a>; <a href="./references#CD010287-bbs2-0009" title="DavarR , JavedaniM , FallahzadehMH . Metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iranian Journal of Reproductive Medicine2011;9(1):31-6. ">Davar 2011</a>; <a href="./references#CD010287-bbs2-0012" title="EL-GharibMN , MahfouzAE , FarahatMA . Comparison of letrozole versus tamoxifen effects in clomiphene citrate resistant women with polycystic ovarian syndrome. Journal of Reproduction and Infertility2015;16(1):30-5. ">El‐Gharib 2015</a>; <a href="./references#CD010287-bbs2-0014" title="ForoozanfardF , MahdianM , Mousavi Gl, PejmanmaneshM , SoleimaniA . Use of letrozole versus clomiphene citrate combined with gonadotropins in patients with clomiphene resistant polycystic ovarian syndrome: A comparative study. Pakistan Journal of Medical Sciences2011;27(5):967-70. ">Foroozanfard 2011</a>; <a href="./references#CD010287-bbs2-0034" title="SeyedoshohadaeiF , TangestaniL , ZandvakiliF , RashadmaneshN . Comparison of the effect of clomiphene- estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research2016;10(8):QC10-13. ">Seyedoshohadaei 2016</a>; <a href="./references#CD010287-bbs2-0038" title="SohrabvandF , AnsariSH , BagheriM . Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction2006;21(6):1432-5. ">Sohrabvand 2006</a>); the other 17 trials included women not resistant to CC (<a href="./references#CD010287-bbs2-0005" title="BayarU , BasaranM , KiranS , CoskunA , GezerS . Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility2006;86(5):1447-51. ">Bayar 2006</a>; <a href="./references#CD010287-bbs2-0010" title="DehbashiS , KazerooniT , RobatiM , AlborziS , ParsanezhadME , ShadmanA . Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences2009;34:23-8. ">Dehbashi 2009</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>; <a href="./references#CD010287-bbs2-0028" title="NazikH , KumtepeY . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. HealthMED Journal2012;6(3):879-83. ">Nazik 2012</a>; <a href="./references#CD010287-bbs2-0032" title="Salazar-OrtizDY , Rodriguez-AntonioM , Contreras-CarretoNA . Comparison of clomiphene citrate and letrozole for induction of ovulation and pregnancy and its effectiveness in patients with infertility [Comparación de la eficacia decitrato de clomifeno vs letrozolen mujeres con infertilidad porsíndrome de ovario poliquístico]. Ginecologia y Obstetricia de Mexico2016;84(11):696-703. ">Salazar‐Ortiz 2016</a>; <a href="./references#CD010287-bbs2-0036" title="Sheikh-El-Arab ElsedeekM , ElmaghrabyHA . Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertility Society Journal2011;16(2):125-30. ">Sh‐El‐Arab Elsedeek 2011</a>), or it was not mentioned (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0004" title="AtayV , CamC , MuhcuM , CamM , KaratekeA . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research2006;34(1):73-6. ">Atay 2006</a>; <a href="./references#CD010287-bbs2-0008" title="ChenZ , ZhangM , QiaoY , YangJ . Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pakistanian Journal of Medical Sciences2016;32(6):1434-8. ">Chen 2016</a>; <a href="./references#CD010287-bbs2-0013" title="El-KhayatW , Abdel MoetyG , MohammadyMA , HamedD . A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics2016;132(2):206-9. ">El‐Khayat 2016</a>; <a href="./references#CD010287-bbs2-0016" title="GhahiriA , MogharehabedN , MamourianM . Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Advanced Biomedical Research2016;5(6):1-4. ">Ghahiri 2016</a>; <a href="./references#CD010287-bbs2-0025" title="LiuC , FengG , HuangW , WangQ , YangS , TanJ , et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecological Endocrinology2017;33(11):872-6. ">Liu 2017</a>; <a href="./references#CD010287-bbs2-0026" title="MoussaAA , TorkyH , DiefO , ElwahedAA , SennaHA . The effect of clomiphene citrate versus tamoxifen versus letrozole on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Medica International2016;3(2):88-92. ">Moussa 2016</a>; <a href="./references#CD010287-bbs2-0033" title="SelimMF , BorgTF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. Journal of Gynaecologic Surgery2012;28(6):405-10. [DOI: 10.1089/gyn.2012.0033]">Selim 2012</a>; <a href="./references#CD010287-bbs2-0035" title="ShariefM , NafeeNR . Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of Pakistani Medical Association2015;65(11):1149-52. ">Sharief 2015</a>; <a href="./references#CD010287-bbs2-0030" title="RayPB , RayA , ChakrabortiPS . Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of Gynecology and Obstetrics2012;285(3):873-7. ">Ray 2012</a>; <a href="./references#CD010287-bbs2-0031" title="RoyK , BaruahJ , SinglaS , SharmaJB , SinghN , JainSK , et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Journal of Human Reproductive Sciences2012;5(1):20-5. ">Roy 2012</a>). </p> <p>Data based on findings from <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a> found that the interventions had comparable treatment costs. This suggests that, given its higher effectiveness, letrozole is more cost‐effective than SERMs (<a href="./references#CD010287-bbs2-0125" title="Reproductive Medicine Network. Letrozole versus clomiphene citrate in anovulatory PCOS women: A cost-effectiveness analysis. Fertility and Sterility2013;100(3):Suppl 128.">Reproductive Medicine Network 2013</a>). </p> </section> <section id="CD010287-sec-0137"> <h4 class="title">Letrozole compared to SERMs with or without adjuncts followed by intrauterine insemination</h4> <p>Three trials compared letrozole to SERMs for ovulation induction followed by intrauterine insemination (<a href="./references#CD010287-bbs2-0015" title="GaneshA , GoswamiSK , ChattopadhyayR , ChaudhuryK , ChakravartyB . Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics2009;26(1):19-24. ">Ganesh 2009</a>; <a href="./references#CD010287-bbs2-0022" title="KarS . Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. Journal of Human Reproductive Sciences2012;5(3):262-5. [DOI: 10.4103/0974-1208.106338]">Kar 2012</a>; <a href="./references#CD010287-bbs2-0041" title="ZeinalzadehM , BasiratZ , EsmailpourM . Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine2010;55(1-2):36-40. ">Zeinalzadeh 2010</a>). None reported live birth. Two reported OHSS: only three cases occurred and there was insufficient evidence of a difference despite a trial population of 1494 women. Clinical pregnancy rates were increased in women treated with letrozole, compared to SERMs and FSH. There was insufficient evidence of a difference in rates of miscarriage or multiple pregnancy. </p> </section> <section id="CD010287-sec-0138"> <h4 class="title">Letrozole compared to LOD</h4> <p>Three trials compared letrozole to LOD in CC‐resistant women (<a href="./full#CD010287-tbl-0002">summary of findings Table 2</a>). There was very low‐certainty evidence of higher live birth rates with letrozole compared to LOD. However, we note that trials reporting live birth tended to report higher clinical pregnancy rates in the letrozole group than trials that failed to report live birth, with insufficient evidence of a difference in miscarriage rates per pregnancy. This suggests that findings might be less favourable to letrozole if all trials reported live birth. OHSS was not reported. There was low‐certainty evidence of no difference in rates of pregnancy, miscarriage or multiple pregnancy rate. </p> </section> <section id="CD010287-sec-0139"> <h4 class="title">Letrozole compared to FSH</h4> <p>Two trials, including 236 women, compared use of letrozole to FSH (<a href="./references#CD010287-bbs2-0018" title="HassanA , ShehataN , WahbaA . Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Human Fertility2017;20(1):37-42. ">Hassan 2017</a>; <a href="./references#CD010287-bbs2-0037" title="ShiS , HongT , JiangF , ZhuangY , ChenL , HuangX . Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. Medicine2020;99(4):e18383. ">Shi 2019</a>). Live birth rate was not reported and there were no events of OHSS. There was insufficient evidence of a difference for clinical pregnancy, miscarriage or multiple pregnancy rates. </p> </section> <section id="CD010287-sec-0140"> <h4 class="title">Letrozole compared to anastrozole</h4> <p>Letrozole was compared to anastrozole in one trial including 40 women (<a href="./references#CD010287-bbs2-0001" title="Al-OmariWR , SulaimanWR , Al-HadithiN . Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynecology &amp; Obstetrics2004;85(3):289-91. ">Al‐Omari 2004</a>). Live birth rate, OHSS rate and miscarriage rate were not reported. There was insufficient evidence of a difference for rates of clinical pregnancy and multiple pregnancies. </p> </section> <section id="CD010287-sec-0141"> <h4 class="title">Letrozole compared to berberine</h4> <p>The results of one trial comparing letrozole to berberine followed by timed intercourse suggest that letrozole improves the live birth rate and pregnancy rate compared to berberine (<a href="./references#CD010287-bbs2-0039" title="WuX , WangY , LiuJ , LiangR , XueH , MaH , et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertility and Sterility2016;106(3):757-66. ">Wu 2016</a>). The OHSS rate was not reported. There was insufficient evidence of a difference for rates of miscarriage and multiple pregnancies. </p> </section> <section id="CD010287-sec-0142"> <h4 class="title">Different administration protocols of letrozole</h4> <section id="CD010287-sec-0143"> <h5 class="title">Letrozole day 3‐7 administration versus day 5‐9 administration protocol</h5> <p>A single trial including 70 women compared a day 3 to 5 versus day 5 to 9 administration protocol. Only pregnancy rate was reported and there was insufficient evidence for a difference. </p> </section> </section> <section id="CD010287-sec-0144"> <h4 class="title">Dosage studies of letrozole</h4> <p>We intended to analyse different doses of letrozole in the range from 2.5 mg/day to 5 mg/day, but we found only one trial including 80 women comparing a dosage of 5 mg/day to 7.5 mg/day. There was insufficient evidence of a difference in effectiveness as only seven pregnancies were reported in each group. There was also insufficient evidence of a difference in adverse events, but the size of the trial population might have been too small because only one or no cases were reported in each group for OHSS, miscarriage and multiple pregnancy rate. </p> </section> </section> <section id="CD010287-sec-0145"> <h3 class="title" id="CD010287-sec-0145">Overall completeness and applicability of evidence</h3> <p>For our main comparison of letrozole compared to SERMs with or without adjuncts followed by timed intercourse, we found sufficient trials for our analysis of live birth and OHSS rates to answer our research question. For all other comparisons except for the comparison of letrozole versus placebo, more trials could improve the certainty of evidence.  </p> <p>Most of the trials included were conducted in Egypt or the Middle East. There are, however, two large trials from the USA and Europe confirming the results (<a href="./references#CD010287-bbs2-0002" title="AmerSA , SmithJ , MahranA , FoxP , FakisA . Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction2017;32(8):1631-8. [CENTRAL: 01405506] ">Amer 2017</a>; <a href="./references#CD010287-bbs2-0023" title="LegroRS , BrzyskiRG , DiamondMP , CoutifarisC , SchlaffWD , CassonP , et al, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine2014;371(2):119-29. LegroRS , KunselmanAR , BrzyskiRG , CassonPR , DiamondMP , SchlaffWD , et al. Effect of letrozole versus clomiphene on live birth in women with anovulatory infertility due to polycystic ovary syndrome (PCOS): A randomized double-blind multi-center trial. Fertility and Sterility2013;100(3):Suppl 51. ">Legro 2014</a>). </p> </section> <section id="CD010287-sec-0146"> <h3 class="title" id="CD010287-sec-0146">Certainty of the evidence</h3> <p>We included 41 trials with 6522 women in the review. We rated the overall certainty of the evidence as high for all outcomes for our main comparison: letrozole versus SERMs, with or without adjuncts followed by timed intercourse (<a href="./full#CD010287-tbl-0001">summary of findings Table 1</a>). Based on the large numbers of participants (number of trials ranging from 10 to 23 depending on the outcome) and the addition of trials at low risk of bias, it is unlikely that additional trials are going to alter the effect estimates of our main comparison. </p> <p>The other comparisons included only one to five trials. We downgraded much of the evidence for risks of bias and imprecision (<a href="./full#CD010287-tbl-0002">summary of findings Table 2</a>). We rated the certainty of the evidence for live birth and multiple pregnancy rates as very low, and as low for clinical pregnancy and miscarriage rates. </p> </section> <section id="CD010287-sec-0147"> <h3 class="title" id="CD010287-sec-0147">Potential biases in the review process</h3> <p>We conducted a comprehensive search with the help of an experienced Information Specialist, and ran extensive manual searches in order to identify all relevant trials and in an effort to minimise the risk of publication bias. We generated a funnel plot for the outcomes of live birth and pregnancy rates in the comparison of letrozole versus SERMs, which was symmetrical and therefore indicated there is no publication bias. </p> <p>We followed Cochrane guidelines to select trials, extract data and assess the certainty and potential risks of different types of biases in all our included trials, in order to minimise the chance of error and bias by the review authors. </p> <p>We requested further information from trial author teams; we did not receive a response from five of them. </p> </section> <section id="CD010287-sec-0148"> <h3 class="title" id="CD010287-sec-0148">Agreements and disagreements with other studies or reviews</h3> <p>Our meta‐analysis shows evidence for increased live birth rates in favour of letrozole when compared to CC in women with PCOS. This differs from a previous review, which did not detect a difference (<a href="./references#CD010287-bbs2-0122" title="MissoML , WongJL , TeedeHJ , HartR , RombautsL , MelderAM , et al. Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Human Reproduction Update2012;18(3):301-12.">Misso 2012</a>). This is most likely due to the limited number of trials included in the previous review. They included six RCTs, comparing the pregnancy rate between letrozole and CC, including 889 women in total (odds ratio (OR) 1.53, 95% CI 0.91 to 2.58). Another recent meta‐analysis is in accordance with our findings of increased live birth rate (risk ratio (RR) 1.55, 95% CI 1.26 to 1.90; I<sup>2 </sup>= 0%; 5 trials, 1289 participants) and pregnancy rate (RR 1.38, 95% CI 1.05 to 1.83; I<sup>2 </sup>= 61%; 7 trials, 1833 participants), as well as no difference for miscarriage and multiple pregnancy rates (<a href="./references#CD010287-bbs2-0127" title="RoqueM , TostesAC , ValleM , SampaioM , GeberS . Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynaecological Endocrinology2015;31(12):917-21. [DOI: 10.3109/09513590.2015.1096337]">Roque 2015</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010287-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for update 2021" data-id="CD010287-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram for update 2021</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010287-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010287-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators (SERMs), outcome: 2.1 Live birth rate." data-id="CD010287-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators (SERMs), outcome: 2.1 Live birth rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 AIs compared to SERMs with or without adjuncts, followed by timed intercourse, outcome: 2.1 Live birth rate." data-id="CD010287-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 AIs compared to SERMs with or without adjuncts, followed by timed intercourse, outcome: 2.1 Live birth rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators SERMs, outcome: 2.6 Ovarian hyperstimulation syndrome rate." data-id="CD010287-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators SERMs, outcome: 2.6 Ovarian hyperstimulation syndrome rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators SERMs, outcome: 2.5 Multiple pregnancy rate." data-id="CD010287-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Aromatase inhibitors compared to selective oestrogen receptor modulators SERMs, outcome: 2.5 Multiple pregnancy rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Letrozole compared to placebo, Outcome 1: Live birth rate" data-id="CD010287-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Letrozole compared to placebo, Outcome 1: Live birth rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Letrozole compared to placebo, Outcome 2: Ovarian hyperstimulation syndrome rate" data-id="CD010287-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Letrozole compared to placebo, Outcome 2: Ovarian hyperstimulation syndrome rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Letrozole compared to placebo, Outcome 3: Clinical pregnancy rate" data-id="CD010287-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Letrozole compared to placebo, Outcome 3: Clinical pregnancy rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Letrozole compared to placebo, Outcome 4: Miscarriage rate per woman" data-id="CD010287-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Letrozole compared to placebo, Outcome 4: Miscarriage rate per woman</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Letrozole compared to placebo, Outcome 5: Miscarriage rate per pregnancy" data-id="CD010287-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Letrozole compared to placebo, Outcome 5: Miscarriage rate per pregnancy</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Letrozole compared to placebo, Outcome 6: Multiple pregnancy rate" data-id="CD010287-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Letrozole compared to placebo, Outcome 6: Multiple pregnancy rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 1: Live birth rate" data-id="CD010287-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 1: Live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 2: Live birth rate by BMI" data-id="CD010287-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 2: Live birth rate by BMI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 3: Live birth rate by first‐ or second‐line treatment" data-id="CD010287-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 3: Live birth rate by first‐ or second‐line treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 4: Impact of allocation bias for live birth rate" data-id="CD010287-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 4: Impact of allocation bias for live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 5: Impact of detection bias for live birth rate" data-id="CD010287-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 5: Impact of detection bias for live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 6: Impact of attrition bias for live birth rate" data-id="CD010287-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 6: Impact of attrition bias for live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 7: Ovarian hyperstimulation syndrome rate" data-id="CD010287-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 7: Ovarian hyperstimulation syndrome rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 8: Ovarian hyperstimulation syndrome rate by BMI" data-id="CD010287-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 8: Ovarian hyperstimulation syndrome rate by BMI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 9: Clinical pregnancy rate" data-id="CD010287-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 9: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 10: Impact of allocation bias for clinical pregnancy rate" data-id="CD010287-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 10: Impact of allocation bias for clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 11: Miscarriage rate per woman" data-id="CD010287-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 11: Miscarriage rate per woman </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 12: Miscarriage rate per pregnancy" data-id="CD010287-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 12: Miscarriage rate per pregnancy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-002.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 13: Multiple pregnancy rate" data-id="CD010287-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-002.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2: Letrozole compared to SERM with or without adjuncts, followed by timed intercourse, Outcome 13: Multiple pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-002.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 1: Ovarian hyperstimulation syndrome rate" data-id="CD010287-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 1: Ovarian hyperstimulation syndrome rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 2: Clinical pregnancy rate" data-id="CD010287-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 2: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 3: Miscarriage rate per woman" data-id="CD010287-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 3: Miscarriage rate per woman </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 4: Miscarriage rate per pregnancy" data-id="CD010287-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 4: Miscarriage rate per pregnancy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 5: Multiple pregnancy rate" data-id="CD010287-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Letrozole compared to SERMs with our without adjuncts, followed by IUI, Outcome 5: Multiple pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 1: Live birth rate" data-id="CD010287-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 1: Live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 2: Clinical pregnancy rate" data-id="CD010287-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 2: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 3: Miscarriage rate per woman" data-id="CD010287-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 3: Miscarriage rate per woman </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 4: Miscarriage rate per pregnancy" data-id="CD010287-fig-0035" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 4: Miscarriage rate per pregnancy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 5: Multiple pregnancy rate" data-id="CD010287-fig-0036" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Letrozole compared to laparoscopic ovarian drilling, Outcome 5: Multiple pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Letrozole compared to FSH, Outcome 1: Live birth" data-id="CD010287-fig-0037" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Letrozole compared to FSH, Outcome 1: Live birth</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Letrozole compared to FSH, Outcome 2: Ovarian hyperstimulation syndrome rate" data-id="CD010287-fig-0038" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Letrozole compared to FSH, Outcome 2: Ovarian hyperstimulation syndrome rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Letrozole compared to FSH, Outcome 3: Clinical pregnancy rate" data-id="CD010287-fig-0039" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Letrozole compared to FSH, Outcome 3: Clinical pregnancy rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Letrozole compared to FSH, Outcome 4: Miscarriage rate per woman" data-id="CD010287-fig-0040" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Letrozole compared to FSH, Outcome 4: Miscarriage rate per woman</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Letrozole compared to FSH, Outcome 5: Miscarriage rate per pregnancy" data-id="CD010287-fig-0041" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Letrozole compared to FSH, Outcome 5: Miscarriage rate per pregnancy</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Letrozole compared to FSH, Outcome 6: Multiple pregnancy rate" data-id="CD010287-fig-0042" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: Letrozole compared to FSH, Outcome 6: Multiple pregnancy rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Letrozole compared to anastrozole, Outcome 1: Clinical pregnancy rate" data-id="CD010287-fig-0043" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Letrozole compared to anastrozole, Outcome 1: Clinical pregnancy rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Letrozole compared to anastrozole, Outcome 2: Multiple pregnancy rate" data-id="CD010287-fig-0044" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Letrozole compared to anastrozole, Outcome 2: Multiple pregnancy rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 1: Live birth rate" data-id="CD010287-fig-0045" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 1: Live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 2: Clinical pregnancy rate" data-id="CD010287-fig-0046" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 2: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 3: Miscarriage rate per woman" data-id="CD010287-fig-0047" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 3: Miscarriage rate per woman </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 4: Miscarriage rate per pregnancy" data-id="CD010287-fig-0048" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 4: Miscarriage rate per pregnancy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-007.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 5: Multiple pregnancy rate" data-id="CD010287-fig-0049" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-007.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7: Letrozole compared to berberine, followed by timed intercourse, Outcome 5: Multiple pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-007.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Different administration protocols of letrozole, Outcome 1: Clinical pregnancy rate" data-id="CD010287-fig-0050" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Different administration protocols of letrozole, Outcome 1: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Dosage studies of letrozole, Outcome 1: Ovarian hyperstimulation syndrome rate" data-id="CD010287-fig-0051" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Dosage studies of letrozole, Outcome 1: Ovarian hyperstimulation syndrome rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Dosage studies of letrozole, Outcome 2: Clinical pregnancy rate" data-id="CD010287-fig-0052" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Dosage studies of letrozole, Outcome 2: Clinical pregnancy rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Dosage studies of letrozole, Outcome 3: Miscarriage rate per woman" data-id="CD010287-fig-0053" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Dosage studies of letrozole, Outcome 3: Miscarriage rate per woman</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Dosage studies of letrozole, Outcome 4: Miscarriage rate per pregnancy" data-id="CD010287-fig-0054" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Dosage studies of letrozole, Outcome 4: Miscarriage rate per pregnancy</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010287-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/urn:x-wiley:14651858:media:CD010287:CD010287-CMP-009.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Dosage studies of letrozole, Outcome 5: Multiple pregnancy rate" data-id="CD010287-fig-0055" src="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_t/tCD010287-CMP-009.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9: Dosage studies of letrozole, Outcome 5: Multiple pregnancy rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/media/CDSR/CD010287/image_n/nCD010287-CMP-009.05.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010287-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Letrozole with or without adjuncts compared to SERMs with or without adjuncts followed by timed intercourse for infertile women with polycystic ovary syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Letrozole with or without adjuncts compared to SERMs with or without adjuncts followed by timed intercourse for infertile women with polycystic ovary syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> infertile women with polycystic ovary syndrome<br/><b>Setting:</b> (fertility) clinics or outpatient settings<br/><b>Intervention:</b> letrozole with or without adjuncts followed by timed intercourse<br/><b>Comparison:</b> SERMs (clomiphene citrate) with or without adjuncts followed by timed intercourse </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with SERMs with or without adjuncts</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with letrozole with or without adjuncts</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live birth rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>307 per 1000<br/>(265 to 352) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.72<br/>(1.40 to 2.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2060<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ovarian hyperstimulation syndrome rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/>(5 to 5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RD −0.00<br/>(−0.01 to 0.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1848<br/>(10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pregnancy rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>242 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>350 per 1000<br/>(316 to 387) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.69<br/>(1.45 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3321<br/>(23 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miscarriage rate per pregnancy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>252 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>240 per 1000<br/>(182 to 307) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.94<br/>(0.66 to 1.32) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>736<br/>(15 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiple pregnancy rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000<br/>(9 to 28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.74<br/>(0.42 to 1.32) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2247<br/>(14 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the mean risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>RD:</b> risk difference; <b>RCT</b>: randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Letrozole with or without adjuncts compared to SERMs with or without adjuncts followed by timed intercourse for infertile women with polycystic ovary syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010287-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Letrozole compared to laparoscopic ovarian drilling for infertile women with polycystic ovary syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Letrozole compared to laparoscopic ovarian drilling compared to placebo for infertile women with polycystic ovary syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> infertile women with polycystic ovary syndrome<br/><b>Setting:</b> (fertility) clinics or outpatient settings<br/><b>Intervention:</b> letrozole with or without adjuncts followed by timed intercourse<br/><b>Comparison:</b> laparoscopic ovarian drilling (LOD) followed by timed intercourse </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with LOD</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with letrozole</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live birth rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>229 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>380 per 1000<br/>(227 to 561) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 2.07<br/>(0.99 to 4.32) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low<sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ovarian hyperstimulation syndrome rate</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>No trials reported on this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pregnancy rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>290 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1000<br/>(279 to 482) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.47<br/>(0.95 to 2.28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>376<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miscarriage rate per pregnancy</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>151 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>104 per 1000<br/>(38 to 254) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.65<br/>(0.22 to 1.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiple pregnancy rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 3.00<br/>(0.12 to 74.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low<sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>RCT</b>: randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Insufficient data to allow judgement of risk of bias in some trials ‐ downgraded one level for serious risk of bias.<br/><sup>b</sup>There is insufficient data to determine if there is a difference as opposed to no evidence of a difference ‐ downgraded one level for imprecision.<br/><sup>c</sup>Analysis is based on only one trial ‐ downgraded one additional level for imprecision.<br/>  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Letrozole compared to laparoscopic ovarian drilling for infertile women with polycystic ovary syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/full#CD010287-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Letrozole compared to placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Ovarian hyperstimulation syndrome rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.05, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [1.08, 7.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Miscarriage rate per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.26, 9.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Miscarriage rate per pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Multiple pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Letrozole compared to placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Letrozole compared to SERM with or without adjuncts, followed by timed intercourse</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2060</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [1.40, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 AIs versus clomiphene citrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1646</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.42, 2.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Aromatase inhibitor + metformin compared to clomiphene + metformin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.89, 3.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Aromatase inhibitor + FSH compared to clomiphene + FSH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.53, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.4 AIs versus clomiphene + estradiol valerate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.54, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Live birth rate by BMI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1880</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.74 [1.41, 2.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 BMI &gt; 25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1428</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [1.44, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 BMI &lt; 25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.98, 2.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Live birth rate by first‐ or second‐line treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 No previous ovulation induction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.22, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 CC‐resistant women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [1.08, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.3 Unclear or mixed study cohort</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [1.31, 2.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Impact of allocation bias for live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Unclear risk of allocation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1031</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.90 [1.42, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Low risk of allocation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1029</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [1.18, 2.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Impact of detection bias for live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2060</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [1.40, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 High risk of detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [0.83, 8.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Low risk of detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.26, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.3 Unclear risk of detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [1.27, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Impact of attrition bias for live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Unclear risk of attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.04 [0.93, 4.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Low risk of attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1645</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [1.39, 2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.3 High risk of attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.85, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Ovarian hyperstimulation syndrome rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1848</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.01, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 AIs versus clomiphene citrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1572</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.01, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 Aromatase inhibitor + hMG versus clomiphene + hMG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Ovarian hyperstimulation syndrome rate by BMI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 BMI &gt; 25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.01, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.2 BMI &lt; 25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>605</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [1.45, 1.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Aromatase inhibitor versus clomiphene citrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [1.42, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.2 Aromatase inhibitor + metformin versus clomiphene + metformin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [1.05, 3.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.3 Aromatase inhibitor + hMG versus clomiphene + hMG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.82, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.4 AIs versus tamoxifen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [0.64, 3.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.5 AIs versus clomiphene + estradiol valerate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.47 [0.94, 6.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Impact of allocation bias for clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.1 Unclear risk of allocation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1931</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.74 [1.41, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.2 Low risk of allocation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>580</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [1.10, 2.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Miscarriage rate per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.01, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.1 AIs versus clomiphene citrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1752</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.98, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.2 Aromatase inhibitor + metformin versus clomiphene + metformin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.52, 2.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.3 Aromatase inhibitor + hMG versus clomiphene + hMG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.31, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.4 AIs versus clomiphene + estradiol valerate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.21 [0.66, 226.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 Miscarriage rate per pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.66, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.1 AIs versus clomiphene citrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>529</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.63, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.2 Aromatase inhibitor + metformin versus clomiphene + metformin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.32, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.3 Aromatase inhibitor + hMG versus clomiphene + hMG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.23, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.4 AIs versus clomiphene + estradiol valerate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.13 [0.39, 167.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.13 Multiple pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.42, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.1 Aromatase inhibitor versus clomiphene citrate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1971</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.35, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.2 Aromatase inhibitor + hMG versus clomiphene + hMG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.29, 3.05]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Letrozole compared to SERM with or without adjuncts, followed by timed intercourse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Letrozole compared to SERMs with our without adjuncts, followed by IUI</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Ovarian hyperstimulation syndrome rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.01, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 AI versus clomiphene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.07, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 AI versus clomiphene + rFSH and rFSH only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.01, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1597</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [1.30, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 AI versus clomiphene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [0.97, 4.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 AI versus clomiphene + rFSH and rFSH only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [1.23, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Miscarriage rate per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.62, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 AI versus clomiphene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 8.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 AI versus clomiphene + rFSH and rFSH only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.66, 2.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Miscarriage rate per pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.37, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 AI versus clomiphene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.00, 3.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 AI versus clomiphene + rFSH and rFSH only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.40, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Multiple pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1597</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.49, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 AI versus clomiphene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.48 [0.14, 87.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.2 AI versus clomiphene + rFSH and rFSH only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.44, 2.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Letrozole compared to SERMs with our without adjuncts, followed by IUI</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Letrozole compared to laparoscopic ovarian drilling</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.95, 2.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 AI versus LOD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [0.96, 2.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 AI + metformin versus LOD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.60, 2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Miscarriage rate per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>367</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.31, 2.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 AI versus LOD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.14, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 AI + metformin versus LOD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.29, 6.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Miscarriage rate per pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.22, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 AI versus LOD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.2 AI + metformin versus LOD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.24, 6.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Multiple pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Letrozole compared to laparoscopic ovarian drilling</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Letrozole compared to FSH</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Ovarian hyperstimulation syndrome rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.08, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.46, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Miscarriage rate per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.19, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 Miscarriage rate per pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 Multiple pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.04, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Letrozole compared to FSH</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Letrozole compared to anastrozole</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Multiple pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Letrozole compared to anastrozole</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Letrozole compared to berberine, followed by timed intercourse</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Miscarriage rate per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 Miscarriage rate per pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.5 Multiple pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Letrozole compared to berberine, followed by timed intercourse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Different administration protocols of letrozole</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Letrozole day 3‐7 administration versus day 5‐9 administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Different administration protocols of letrozole</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010287-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Dosage studies of letrozole</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Ovarian hyperstimulation syndrome rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 5 mg versus 7.5 mg letrozole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.1 5 mg versus 7.5 mg letrozole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Miscarriage rate per woman <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3.1 5 mg versus 7.5 mg letrozole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 Miscarriage rate per pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4.1 5 mg versus 7.5 mg letrozole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.5 Multiple pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.5.1 5 mg versus 7.5 mg letrozole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Dosage studies of letrozole</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010287.pub4/references#CD010287-tbl-0011">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010287.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010287-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010287-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010287-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010287-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD010287-note-0010">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD010287-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD010287-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD010287-note-0013">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010287-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010287\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010287\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010287\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010287\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010287\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=cdmLYOAV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010287.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010287.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010287.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010287.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010287.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724378644"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010287.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724378648"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010287.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e615cba47f3fd',t:'MTc0MDcyNDM3OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 